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NEW YORK STATE'S PROPOSAL TO UNBLIND HIV
TESTING FOR NEWBORNS: A NECESSARY STEP IN
ADDRESSING A CRITICAL PROBLEM
INTRODUCTION
Imagine the tragedy of a mother who rushes her sick in-
fant to the hospital because the child is suffering from chest
congestion and fever and learns that her child is infected with
Human Immunodeficiency Virus ("HIV"), the causative agent
of Acquired Immune Deficiency Syndrome ("AIDS"). Imagine
the greater tragedy when the mother also learns that, if her
child had been diagnosed with the HIV infection earlier, the
deadly pneumonia her child has developed as a result of the
infection could have been prevented.'
Each year in the United States, approximately 6000 babies
are born to mothers who are HIV-positive. About one-third of
these babies, or 2000 newborns, will be infected with the virus
through perinatal transmission (transmission from mother to
child in utero or during birth).2 In New York State, the situa-
tion is especially distressing: the state has one-fourth of the
nationally reported cases of perinatal HIV transmissions.'
Even more disturbing is that, of the approximately 500 chil-
dren who are perinatally infected in New York State annually,
about 200 to 300 babies each year will leave New York State
hospitals without having their infection identified.4 These chil-
dren will receive no treatment for their illnesses until some -
time later when they begin to show symptoms of their deadly
1 See Test All Newborns for AIDS, N.Y. NEwsDAY, Apr. 21, 1991, at 31 (edito-
rial).
2 ASSOCIATION TO BENEFIT CHILDREN, A PREVENTABLE CRISIS: A SPECIAL RE-
PORT ON THE FAILURE TO TEST AND TREAT INFANTS AND CHILDREN FOR HIV 10-11
& nn.5-8 (1993) [hereinafter PREVENTABLE CRISIS].
' Id. at 12 & n.12.
AIDS Babies Pay the Price, N.Y. TIMES, Aug. 13, 1993, at A26 (editorial);
Gretchen Buchenholz, H1V Babies Have Rights, Too, N.Y. DAILY NEWS, Jan. 18,
1994, at 15.
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infection.5 By then, it may be too late.
The shocking fact is that New York State does test all
newborns for HIV, but because the purpose of this testing is to
acquire data for epidemiological studies, the test results are
blinded-i.e., anonymous-and neither the mothers nor the
doctors of the newborns are informed of the newborns' HIV
status. Until recently, legislators have been unwilling to
unblind the results of these tests because, by revealing the
HIV-positive ("seropositive") status of the newborn, the sero-
positive status of the mother is also revealed.7 Thus far, the
civil liberties and privacy interests of the mothers have been
deemed to outweigh the potential benefits of early treatment
for the children.8
Recent advances in medical treatments, however, have
shifted the balance between these competing interests. In the
past few years, for example, effective treatments have become
available for pneumocystis carinii pneumonia ("PCP"), one of
the prime killers of children with AIDS. Both the United
States Centers for Disease Control ("CDC") and the New York
State Department of Health ("NYSDOH") have recommended
that treatment for PCP be administered early, beginning in the
first month of a newborn's life, to be most effective.9
In March 1993, Assemblywoman Nettie Mayersohn of
Queens introduced a bill in the New York State Assembly that
would require the results of newborn HIV tests to be released
to the parents of the tested newborns." Because of its contro-
' Symptoms associated with HIV infection include pneumonia, swollen lymph
glands, persistent diarrhea and failure to thrive. GERALD J. STINE, ACQUIRED IM-
MUNE DEFICIENCY SYNDROME: BIOLOGICAL, MEDICAL, SOCIAL, AND LEGAL ISSUES
113 (1993).
6 Id. at 317. New York began blinded newborn testing for HIV in 1987. When
a blinded test is performed on a newborn, the newborn's name is removed from
his or her blood sample and replaced with a bar code, leaving only hospital infor-
mation and the newborn's demographic data on the sample. After the newborn's
name is removed, it is impossible to trace the test result back to the newborn. Id.
See infra notes 26-41 and accompanying text.
PREVENTABLE CRISIS, supra note 2, at 15; AIDS Babies Pay the Price, supra
note 4, at A26; Nan D. Hunter, Complications of Gender: Women and HIV Disease,
in AIDS AGENDA: EMERGING ISSUES IN CIVIL RIGHTS 5, 23-27 (Nan D. Hunter &
William B. Rubenstein eds., 1992).
9 PREVENTABLE CRISIS, supra note 2, at 14, 19-20 & nn.25-27; see infra note
150.
"9 New York State Assembly Bill No. 6747, 215th Gen. Assembly, 1st Sess.
(1993). This bill was subsequently amended in June 1993, March 1994 and April
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versial nature, the bill has remained stalemated in the Assem-
bly Health Committee since its introduction.1
This Note argues that, given the current availability of
effective treatments for newborns infected with HIV, unblinded
mandatory testing is supported by state informed-consent
principles, federal constitutional principles, and policy consid-
erations. Accordingly, this Note urges the New York State As-
sembly to pass Assemblywoman Mayersohn's bill when it is
presented again.
In Parts I and II, this Note provides the pertinent medical
and legal background, respectively, for analyzing the issues
related to HIV. Part III analyzes the right of a mother to give
informed consent to an HIV test for her child and argues that
the benefits of early detection and treatment for a newborn
provide a basis for overriding this right of informed consent.
Part IV assesses the need for mandatory testing, in light of the
failure of voluntary testing, and favorably balances the benefits
of such testing against the costs. Part V then analyzes the
Fourth Amendment, equal protection and privacy issues impli-
cated by unblinded mandatory newborn testing for HIV and
concludes that such testing is constitutional. Finally, Part VI
critically analyzes Assemblywoman Mayersohn's bill and sug-
gests how it should be improved.
I. MEDICAL BACKGROUND
A. The Nature of HIV Infection
HIV is the virus that causes AIDS.12 Although it has be-
1994. The latest version is New York State Assembly Bill No. 6747-C, 215th Gen.
Assembly, 1st Sess. (1994).
" Last year, the bill was blocked by a narrow ten-to-nine vote. John Riley,
Testing Newborns For AIDS Debated, N.Y. NEWSDAY, Nov. 11, 1993, at 22. This
year, the bill was blocked by an even nine-to-nine vote. Jim Dwyer, You Call This
A Compromise?, N.Y. NEWSDAY, July 4, 1994, at A2. The bill has been so contro-
versial that Senator Michael Tully of Port Washington removed the Senate version
from the Senate Health Committee's agenda, preventing that committee from vot-
ing on their version. Id. Nonetheless, if Assemblywoman Mayersohn is re-elected
this year, she will introduce the bill again next year. Telephone Interview with
William Viscovich, General Counsel to Assemblywoman Nettie Mayersohn, 27th
Dist. of Queens (Aug. 8, 1994). See infra part VI. (discussing Assemblywoman
Mayerson's proposed bill).
12 STINE, supra note 5, at 44. There is a small minority in the scientific com-
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come common to speak of the "spread of AIDS,"13 this phrase
is misleading because it is HIV that is transmitted, not AIDS.
AIDS is the term that describes the late stage of illness
brought on by HIV infection.
14
HIV (the human immunodeficiency virus) is so named
because the virus attacks and destroys a person's CD4
cells-cells that play an essential role in the proper functioning
of a person's immune system. 5 These CD4 cells are a type of
lymphocyte, or white blood cell. Together with other lympho-
cytes, they recognize foreign substances in the body (called
antigens) and attempt to eliminate them by producing special
proteins (called antibodies) that either destroy the antigens or
mark them for destruction by other cells.'" When the CD4
cells themselves are destroyed, the ability of the body's im-
mune system to produce antibodies, and thus the body's ability
to defend itself against antigens, is impaired.'"
munity that does not believe HIV is the causative agent of AIDS. Id. at 41. One
of the most vocal and well-known of these critics is Peter Duesberg, a molecular
biologist at the University of California at Berkeley and a member of the National
Academy of Sciences, who believes that factors such as drug abuse and malnutri-
tion-not HIV--cause AIDS. Id. Other scientists, inclunding Luc Montagnier, the
codiscoverer of HIV, have taken the more moderate position that there are certain
bacterial cofactors that are necessary to activate HIV. Lamar Graham, The Heretic,
GENTLEMEN'S Q., Nov. 1993, at 242, 269. After years of research on this issue, one
scientist has written a book detailing what he believes are the shortcomings of the
HIV theory. ROBERT S. ROOT-BERNSTEIN, RETHINKING AIDS: THE TRAGIC COST OF
PREMATURE CONSENSUS (1993). Nonetheless, most scientists believe that the high
correlation between HIV infection and the development of AIDS is compelling evi-
dence that HIV is the cause of AIDS. STINE, supra note 5, at 41-44.
13 See, e.g., Only ABC Has Used Them: Gov't Condom Ads Seldom Used, N.Y.
NEWSDAY, Jan. 28, 1994, at 81 ("Federal Health officials made front-page news
earlier this month with the unveiling of a new series of TV commercials that for
the first time frankly advocate the use of latex condoms to prevent the spread of
AIDS.") (emphasis added); Deborah Wallace, Regional Plan Needed To Stop AIDS
Spread, N.Y. NEWSDAY, Feb. 1, 1994, at 73 ("A great reform . . . must be under-
taken if we are to deal with the spread of AIDS in the New York metropolitan
area.") (emphasis added).
14 STINE, supra note 5, at 33-35; Steven Eisenstat, An Analysis of the Rational-
ity of Mandatory Testing for the HIV Antibody: Balancing the Governmental Public
Health Interests With the Individual's Privacy Interest, 52 U. PrlT. L. REv. 327,
329 n.10 (1991).
1 STINE, supra note 5, at 35; Eisenstat, supra note 14, at 329. CD4 cells are
also called T4 helper cells. STINE, supra note 5, at 6 (Table 1-1).
16 STINE, supra note 5, at 5.
17 STINE, supra note 5, at 35. Once a person is infected with HIV, the progres-
sion of the disease may be monitored by tracking the person's CD4 cell count.
Nancy Wade, Immunologic Considerations in Pediatric HIV Infection, 119 J. PEDI-
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As the HIV infection progresses, and the body's immune
system becomes weaker, HIV-infected persons become suscepti-
ble to opportunistic infections. Opportunistic infections refer to
infections from fungi, bacteria and viruses (other than HIV)
that are typically present in the body, but are normally non-
pathogenic because the immune system is capable of control-
ling them.18 These opportunistic infections cause the death of
the great majority of HIV-infected individuals. 9
B. Transmission of HIV in Children
In adults, HIV is usually transmitted in one of three ways:
through sexual contact with infected persons, through the
receipt of contaminated blood transfusions, or through the use
of shared contaminated intravenous needles." In contrast, the
leading mode of infection in children,21 accounting for 93% of
the cases, is perinatal transmission from infected women."
ATRICS S5, S5 (1991).
' STINE, supra note 5, at 12.
, STINE, supra note 5, at 71 ("About 88% of deaths related to HIV infection
and AIDS are caused by [opportunistic infections], compared with 7% due to can-
cer and 5% due to other causes.") (statistics are for the general population of HIV-
infected persons); Margaret H. Burroughs & Paul J. Edelson, Medical Care of the
HIV-Infected Child, 38 PEDIATRIC CLINICS N. AM. 45 (1991).
Opportunistic infections are the cause of death in more than 60% of pa-
tients. The case fatality rate after diagnosis of an opportunistic infection
is 85%. Seventy-five percent of children who develop an opportunistic
infection will not survive longer than a year ... [O]pportunistic infec-
tions and not HIV infection per se are the cause of death in HIV-infected
children.
Id. at 63 (statistics are for pediatric HIV cases).
2 Eisenstat, supra note 14, at 330-31.
2, The CDC defines pediatric AIDS cases as those cases occurring in children
under 13 years of age. CENTERS FOR DISEASE CONTROL AND PREVENTION,
HIV/AIDS SURVEILLANCE REP., July 1993, at 18 [hereinafter CDC SURVEILLANCE].
Unless otherwise stated, reference to children in this Note should be understood to
refer to children under 13 years of age.
NEW YORK STATE AIDS ADVISORY COUNCIL, REPORT OF THE SUBCOMMITrEE
ON NEWBORN HIV SCREENING 5 (1994) [hereinafter SUBCOMMITTEE REPORT]; see
STINE, supra note 5, at 249 ("Eventually, 99% of newborn AIDS cases will result
from parental transmission."); Working Group on Antiretroviral Therapy, National
Pediatric HIV Resource Center, Antiretroviral Therapy and Medical Management of
the Human Immunodeficiency Virus-Infected Child, 12 PEDIATRIC INFECTIOUS DIS-
EASE J. 513, 514 (1993) [hereinafter Medical Management of HIV] ("essentially all
new cases of EIV infection in young children occur as a result of maternal to
infant transmission"); Burroughs & Edelson, supra note 19, at 45 (among the cases
BROOKLYN LAW REVIEW
Perinatal HIV infection can occur either in utero (similar
to perinatally transmitted rubella) or at the time of delivery,
when the infant is exposed to large volumes of infected fluids
(similar to perinatally transmitted hepatitis B). Fortunately,
not all infants born to infected mothers will become infected
themselves. Studies have shown that the rate of perinatal
transmission is approximately one-in-three, with estimates
ranging from 15 to 39%.3
Nevertheless, even when infants born to infected mothers
are not perinatally infected, they are still at risk for other
modes of infection. For example, an infant may become infect-
ed through breastfeeding.24 As a result, both the CDC and the
NYSDOH currently recommend that HIV-infected mothers
avoid breastfeeding their children."
C. HJV Testing Methods
Pediatric HIV is diagnosed in one of two ways: a child
either displays symptoms associated with the infection or tests
positive for HIV by a Federal Drug Administration ("FDA")-
approved testing method.26 Currently, the most widely avail-
able tests are the Enzyme-Linked Immunosorbent Assay
("ELISA") and the Western blot. These tests do not detect the
presence of HIV, but instead detect the presence of antibodies
to HIV. Adults usually develop antibodies to HIV
("seroconversion") within six to twelve weeks after exposure to
of pediatric AIDS collected by the CDC through April 1990, 82% of children na-
tionally were infected perinatally; as of April 1990, New York City Department of
Health surveillance data showed 88% of pediatric AIDS cases in New York City
were perinatally transmitted).
' Compare SUBCOMMITTEE REPORT, supra note 22, at 9 (estimate of 15% to
25%) with Burroughs & Edelson, supra note 19, at 46 (estimate of 21% to 39%).
Burroughs and Edelson point out that the "[e]stimates of transmission in general
favor children with lower incubation periods and, thus, probably underestimate the
true rate of transmission." Id. On the other hand, Martha Field, a professor of law
at Harvard Law School and a well-respected commentator on women's and
children's issues, points out that the transmission rate has dropped over time and
that some believe that the current rate of 30% is too high. Martha A. Field, Preg-
nancy and AIDS, 52 MD. L. REV. 402, 406 n.12 (1993).
2 Burroughs & Edelson, supra note 19, at 46; Field, supra note 23, at 407.
21 See Hermann Mendez, Ambulatory Care of HIV-Seropositive Infants and
Children, 119 J. PEDIATRICS S14, S17 (1991); Medical Management of HIV, supra
note 22, at 520.
"' See STINE, supra note 5, at 317.
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the virus. Some infected persons, however, may not develop
detectable antibodies for as long as eighteen months." Al-
though these infected persons will test negative until
seroconversion occurs, they are capable of transmitting the
virus prior to seroconversion.28
Properly performed, the ELISA and Western blot tests are
highly accurate. These tests have a sensitivity (the percentage
of infected persons who actually test positive) and a specificity
(the percentage of uninfected persons who actually test nega-
tive) of greater than 99%.29 In addition, to safeguard against a
false positive result (a positive test result for an uninfected
person), a person is usually considered HIV-positive only after
positive results from two ELISA tests and one confirmatory
Western blot test.0 It is expected that future improvements
to these tests will further increase their accuracy.3 '
Although these antibody tests have been used with great
success in adults, the use of these tests in newborn infants has
been problematic. Because newborns acquire their mothers'
antibodies at birth, all infants born to seropositive mothers
will test positive to an HIV-antibody test even though they are
not themselves infected with the virus. The median time for
loss of these maternal antibodies by infants ("seroreversion")
has been estimated to be seven to ten months, but it may take
as long as fifteen to sixteen months." Any diagnosis before
2 Stephen Arpadi & William B. Caspe, HIV Testing, 119 J. PEDIATRICS S8, S8
(1991).
28 Eisenstat, supra note 14, at 332.
29 Arpadi & Caspe, supra note 27, at S9.
" STINE, supra note 5, at 294; Arpadi & Caspe, supra note 27, at S9. The
false positive rate is related to the specificity and varies inversely with the
seroprevalence rate of the tested population. The seroprevalence rate is the num-
ber of people infected with HIV per 1000. As the seroprevalence rate increases,
the false positive rate decreases. See STINE, supra note 5, at 296; Eisenstat, supra
note 14, at 332-33 & n.38. Some commentators have noted that testing a popula-
tion with a low seroprevalence rate would be a problem because of the correspond-
ingly high false positive rate. See STINE, supra note 5, at 296; Eisenstat, supra
note 14, at 332-33 & n.38. Newborn testing in New York would not suffer from
this difficulty because the HIV seroprevalence rate of these newborns is the high-
est in the country. Marta Gwinn et al., Prevalence of HIV Infection in Childbear-
ing Women in the United States, 265 JAMA 1704, 1704 (1991); Lloyd F. Novick et
al., HIV Seroprevalence in Newborns in New York State, 261 JAMA 1745, 1745
(1989).
" Arpadi & Caspe, supra note 27, at S9.
32 COMMITTEE ON INFECTIOUS DISEASES, AMERICAN ACADEMY OF PEDIATRICS,
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this time by an ELISA or Western blot test reveals only the
infants who are potentially infected, not those who are truly
infected.
Because of the shortcoming of the ELISA and Western blot
tests, several other techniques have been developed that are
useful in the early detection of the infection in newborns.
While these techniques are not yet as widely available as the
ELISA or Western blot, they are rapidly becoming more popu-
lar. One of these techniques, called the polymerase chain reac-
tion ("PCR") test, is used to amplify small quantities of HIV
DNA to a level at which it can be detected. The PCR test is so
sensitive that it can detect one molecule of HIV DNA in ten
microliters of blood. 3 Moreover, the PCR test produces no
false positive results, can identify greater than 90% of infected
infants by three months of age, and takes only a few days to
perform.34 For these reasons, the PCR test is quickly becom-
ing the preferred method of early diagnosis in newborns.35
Another technique for early detection of HIV infection in
infants is called the p24 antigen test. This test detects p24, a
protein found in the core of HIV.36 Originally, this test had a
very low sensitivity when performed on infants less than one
month old,3 but in a recent study that used a simple varia-
tion on the test, the test succeeded in correctly identifying the
HIV infection status of 100% of infants tested by three weeks
of age.38 This recently modified p24 antigen test promises to
REPORT ON THE COMMITTEE OF INFECTIOUS DISEASES 121 (George Peter et al. eds.,
22d ed. 1991); Arpadi & Caspe, supra note 27, at S8; Burroughs & Edelson, supra
note 19, at 47.
33 STINE, supra note 5, at 302.
" See Field, supra note 23, at 424 n.82 (PCR can detect greater than 90% of
infected infants by three to six months of age); HIV Detected in Babies as Young
as One Month of Age, AIDS ALERT, Jan. 1993, at 9 (PCR can detect 50% of infect-
ed infants during the first week of life, 70% of infected infants by three weeks of
life, 95% of infected infants by three months of life, and 100% of infected infants
after six months of life).
" Field, supra note 23, at 424 n.82 ("The PCR is likely soon to become the
preferred method of early diagnosis. It is already becoming more widely used and
can be performed by some commercial laboratories. Within the year, a kit for HIV
diagnosis using PCR is likely to be available.").
3 STINE, supra note 5, at 103-04; Field, supra note 23, at 424 n.82.
'7 See Marianne Burgard et al., The Use of Viral Culture and P24 Antigen
Testing to Diagnose Human Immunodeficiency Virus Infection in Neonates, 327
NEW ENG. J. MED. 1192, 1194 (1992) (the sensitivity of the p24 antigen test at
birth was only 18%).
" Steven A. Miles et al., Rapid Serologic Testing With Immune-Complex-Disso-
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1994] PROPOSAL TO UNBLIND HIV TESTING FOR NEWBORNS 415
be an accurate, inexpensive and rapid diagnostic technique for
HIV infection in newborns. 39
A third test, called the IgA test, is similar to the ELISA
and Western blot tests in that it detects antibodies to HIV.
Unlike the other two antibody tests, however, the IgA test
detects antibodies that do not cross the placenta.4" With the
IgA test, 66% of newborns can be identified before three
months of age and close to 99% of newborns can be identified
before six months of age.4'
D. Treatments Available for HIV-Infected Children
Although there is as yet no cure for HIV infection, there
are a variety of treatments today that will enhance the dura-
tion and the quality of life of an infected child.42 Moreover,
ciated HIV P24 Antigen For Early Detection of HIV Infection in Neonates, 328 NEW
ENG. J. MED 297, 299-300 (1993). This study tested twenty-nine infants. The re-
searchers took a blood sample from the umbilical cord of each infant at birth and
a follow-up blood sample from each infant before his or her three-week birthday.
Id. The testing conducted on the umbilical cords produced only a sensitivity of
63% and a specificity of 91%, but the testing conducted on the follow-up samples
correctly identified the HIV infection status of all of the newborns (sensitivity and
specificity of 100%). Id.
" Id. at 301; Test Determines HIV Status of Infants at Early Stage, AIDS
WEEKLY, Feb. 8, 1993, at 7 (test could be performed by any commercial lab in the
United States and would cost only about $80).
" STINE, supra note 5, at 306-07; Field, supra note 23, at 425 n.82. IgA refers
to the type of antibody tested. Even though there are an endless variety of anti-
gens, there are only five general types of antibodies-gamma (IgG), mu (IgM),
alpha (IgA), delta (IgD), and epsilon (IgE). STINE, supra note 5, at 15. The ELISA
and Western blot tests detect the presence of the IgG antibody, which has the
unfavorable characteristic (for newborn testing purposes) of crossing the placenta.
Id. at 306-07.
' STINE, supra note 5, at 306-07.
42 See PREVENTABLE CRISIS, supra note 2, at 16 ("In [the view of the Associa-
tion to Benefit Children] there are now effective treatments for pediatric HIV that
can 'substantially ameliorate the disease for the child,' if not yet cure the in utero
child and its mother.. . ."); SUBCOMMITTEE REPORT, supra note 22, at 32 ("It is
clear that significant improvements in quality and possibly length of life, especially
as a result of PCP prevention, can be achieved once an infant is identified and
under medical supervision."); STINE, supra note 5, at 113 ("Few children infected
as fetuses live beyond two years and survival past three years used to be rare;
but with better therapy now available, some children born with HIV are still alive
at five, 10 and 12 years old."); Medical Management of HIV, supra note 22, at
513-14 ("Childhood infection with [HIVI, like certain childhood cancers, cystic fibro-
sis, diabetes, sickle cell disease and other chronic illnesses, is incurable but not
untreatable. A variety of interventions are now available which have been shown
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the literature is nearly unanimous in recognizing that early
diagnosis and intervention is essential in maximizing the bene-
fits of available treatments.43 These benefits include the ad-
to improve the quality and duration of life for HIV-infected children and new
advances are continuing."); Burroughs & Edelson, supra note 19, at 61 ("Although
there is currently no cure for pediatric HIV disease, early recognition and im-
proved medical care have changed the face of pediatric HIV disease from an acute-
ly fatal illness to a chronic disease of childhood."); see also Fredrick Z. Bierman,
Guidelines for Diagnosis and Management of Cardiac Disease in Children with
H1V Infection, 119 J. PEDIATRICS S53 (1991); Carolyn Butler et al., Approach to
Neurodevelopmental and Neurologic Complications in Pediatric HIV Infection, 119
J. PEDIATRICS S41 (1991); Sarmistha B. Hauger, Approach to the Pediatric Patient
with H1V Infection and Pulmonary Symptoms, 119 J. PEDIATRICS S25 (1991); Mar-
garet Hilgartner, Hematologic Manifestations in HIV-Infected Children, 119 J. PEDI-
ATRICS S47 (1991); Keith Krasinski, Retroviral Therapy and Clinical Trials for
HIV-Infected Children, 119 J. PEDIATRICS S63 (1991); Stephen W. Nicholas et al.,
Guidelines for Nutritional Support of HIV-Infected Children, 119 J. PEDIATRICS S59
(1991); Stephen W. Nicholas, Management of the HIV-Positive Child with Fever,
119 J. PEDIATRICS S21 (1991); Keith R. Powell, Approach to Gastrointestinal Mani-
festations in Infants and Children with HIV Infection, 119 J. PEDIATRICS S34
(1991); Neil Prose, Guidelines for Treatment of Skin Diseases in Children with HIV
Infection, 119 J. PEDIATRICS S57 (1991). But cf Working Group on HIV Testing of
Pregnant Women and Newborns, HIV Infection, Pregnant Women, and New-
borns-A Policy Proposal for Information and Testing, 264 JAMA 2416, 2418-19
(1990) [hereinafter HIV Infection, Pregnant Women, and Newborns] (although medi-
cal benefits for 30% of newborns who are infected are significant, "benefit-to-harm
calculus" may tip in the opposite direction for 70% of newborns who are not in-
fected).
" Burroughs & Edelson, supra note 19, at 63 ("[Plrophylaxis, early recognition,
and improved treatment of opportunistic infections are likely to improve the sur-
vival of HIV-infected children."); Miles et al., supra note 38, at 297 ("Because early
intervention with antiretroviral therapy can substantially decrease the risk of op-
portunistic infections and may improve the survival of patients with HIV infection,
the rapid determination of whether a child is infected with HIV is important.")
(footnotes omitted); R.J. Simonds et al., Pneumocystis Carinii Pneumonia Among
US Children With Perinatally Acquired HIV Infection, 270 JAMA 470, 473 (1993)
("Thus, effective efforts to prevent PCP in HIV-infected children will require early
identification of potentially infected children, either by diagnosis of maternal HIV
infection before birth or by identification of the HIV-exposed infant as soon as
possible after birth."); Larry Wissow & Nancy Hutton, Testing Newborns for Expo-
sure to Human Immunodeficiency Virus (HIV): Not Mandatory but Highly Recom-
mended, 2 PEDIATRIC AIDS & HIV INFECTION 123, 125 (1991) ("There are clear
benefits to children if identified early in the course of HIV infection."); Medical
Management of HIV, supra note 22, at 514 ("[Tlhe HIV infection status of the in-
fant must be determined as soon as possible after birth."); HIV Infection, Pregnant
Women, and Newborns, supra note 42, at 2418-19 ("[W]e are persuaded that for
the approximately 30% of newborns who are infected, the prospects for medical
benefits are significant and would be enhanced by early identification of 'at risk'
status."); Letter from Nilsa Gutierrez, Medical Director of NYSDOH, to the Health
Care Community 1 (Feb. 1993) ("The enclosed protocols emphasize early medical
intervention as essential to the improvement of both survival and quality of life.")
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ministration of prophylaxis, antiretroviral drugs, intravenous
immunoglobulin, specialized immunization schedules and close
nutritional monitoring.
An early HIV diagnosis in children is of major benefit
because it permits the prompt application of prophylaxis for
various opportunistic infections including PCP, tuberculosis,
varicella, meningitis, mycobacterium avium complex and
thrush." Of these, PCP is by far the most common and seri-
ous opportunistic infection that afflicts children infected with
HIV. One recent study conducted by the CDC's Division of
HIV/AIDS reported that PCP occurred in 37% of the
perinatally acquired AIDS cases collected by the CDC.4" As of
the date of the study, 67% of the children infected with PCP
had died and the estimated median survival after diagnosis
was a short nineteen months." The study reported that most
children contract PCP at a very early age: 53% of all
perinatally acquired AIDS cases with PCP occurred in children
three to six months of age. Furthermore, the study estimated
that the risk of contracting PCP by an HIV-infected child was
7 to 20% in the first year of life." These horrifying statistics
demonstrate the urgency of identifying infected infants and
administering effective prophylaxis as early as possible.4"
(on file with author).
" Medical Management of H1V, supra note 22, at 521 (Table 6).
Simonds et al., supra note 43, at 471.
4 Simonds et al., supra note 43, at 471-72. Interestingly, this study found that
the median survival for children diagnosed with POP after 1990 (21 months) was
longer than for those diagnosed with PCP before 1990 (12 months). Id. at 472.
The survival period for children diagnosed before 1990 was closer to the survival
period of one to eight months that had been reported in earlier studies. Id. at
473. The authors of this study suggest that the longer survival period for the
children diagnosed after 1990 indicates that PCP is being successfully diagnosed
and treated earlier and that the use of antiretroviral therapy has become more
widespread. Id. If this is indeed the case, then it is further evidence of the value
of early intervention.
47 Simonds et al., supra note 43, at 471-72.
" Simonds et al., supra note 43, at 473. PCP prophylaxis is not administered
to all infants because it produces adverse reactions in some patients. For this
reason, prophylaxis is administered only after a child tests positive for HIV and
his or her CD4 cell count drops below a level at which the child is considered
vulnerable to opportunistic infections. See AIDS INST., NYSDOH, HIV MEDICAL
EVALUATION AND PREVENTATIVE CARE FOR CHILDREN 5 (1993) (Table 3) [hereinaf-
ter AIDS INST., MEDICAL EVALUATION]; Medical Management of HIV, supra note
22, at 515; Centers for Disease Control and Prevention, Guidelines for Prophylaxis
Against Pneumocystis Carinii Pneumonia for Children Infected With Human Immu-
BROOKLYN LAW REVIEW
An early diagnosis of pediatric HIV infection also provides
the opportunity to administer antiretroviral drugs sooner.
These drugs, the most popular of which is zidovudine
("ZDV"),49 have been shown to delay the progression of HIV
infection, decrease the frequency of opportunistic infections,
and improve cognitive and neurological functions in adults."°
It is not known whether ZDV will prolong survival for children
as it has in adults, but studies indicate that ZDV treatment
improves children's appetites, weight gain and CD4 cell
counts.5" Most importantly, ZDV significantly improves the
mental and cognitive development of children." In one inves-
tigation, two-thirds of the children studied showed mental
deterioration after HIV infection.53 With ZDV treatment, all of
the children improved. In fact, one child whose IQ had fallen to
twenty-eight points after HIV infection improved to ninety-
nine points after ZDV treatment. 4 Antiretroviral treatment
has been recommended both for children who show symptoms
of HIV infection55 and for those who have low CD4 cell counts
(indicating significant immunodeficiency).56
nodeficiency Virus, 265 JAMA 1637, 1640 (1991) [hereinafter CDC Guidelines].
4' Formerly azidothymidine ("AZT").
5' See AIDS INST., NYSDOH, ANTIRETROVIRAL THERAPY MANAGEMENT FOR
ADULT AND PEDIATRIC PATIENTS 1 (1993) [hereinafter AIDS INST., ANTIRETROVIRAL
THERAPY]; STINE, supra note 5, at 131-37. Between 1982 and 1989 in New York
City, ZDV doubled the life expectancy of patients with AIDS. Id. at 132. ZDV has
side effects, however, including nausea, rash, insomnia, vomiting, headaches, and
severe loss of red blood cells that may require a blood transfusion. Id. at 133.
51 STINE, supra note 5, at 136. Moreover, the results from one recent clinical
trial show that infants less than three months old can safely receive ZDV in doses
considered sufficient for anti-HIV activity. Phase-1 Evaluation of Zidovudine Ad-
ministered to Infants Exposed at Birth to the Human Immunodeficiency Virus,
AIDS WEEKLY, Mar. 1, 1993, at 22.
52 AIDS INST., ANTIRETROVIRAL THERAPY, supra note 50, at 9; STINE, supra
note 5, at 136; Pim Brouwers et al., Effect of Continuous-Infusion Zidovudine Ther-
apy on Neuropsychologic Functioning in Children with Symptomatic Human Immu-
nodeficiency Virus Infection, 117 J. PEDIATRICS 980 passim (1990).
s STINE, supra note 5, at 136.
' STINE, supra note 5, at 136.
5 AIDS INST., ANTIRETROVIRAL THERAPY, supra note 50, at 9.
5 Medical Management of HIV, supra note 22, at 515. The authors recommend
that antiretroviral therapy be initiated slightly before PCP prophylaxis is initiated.
For example, CDC guidelines indicate that for a child less than one year old PCP
prophylaxis should be initiated when the child's CD4 cell count falls below
1500/mm'. The authors recommend that, in children of this age, antiretroviral
therapy should begin when the CD4 cell count falls below 1750/mm'.
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In addition to prophylactic and antiretroviral drugs, an
early diagnosis of HIV infection in children permits a doctor to
provide intravenous immunoglobulin ("IVIG") to infected chil-
dren. IVIG is a drug containing antibodies that help boost a
person's immune system.5" Children using IVIG have shown a
reduced occurrence of bacterial infection and a reduced need
for hospitalization."
Another reason early identification of HIV infection in
children is important is. that the schedule of immunizations for
infected children calls for significant modifications from the
schedule for uninfected children. For example, the live or Sa-
bin polio vaccine should be replaced with the inactivated, in-
jectable Salk polio vaccine." In addition, the influenza vac-
cine should be administered every two months until the infant
is six months old and then should be administered annually."
Acceleration of the measles vaccination schedule is also war-
ranted in high HIV seroprevalence areas, and increased fre-
quency of the vaccine may also be warranted during measles
season or during an outbreak of the disease.6 Furthermore,
because some HIV-infected children do not respond to the mea-
sles vaccine, close supervision of these children is necessary
and IG should be administered if the measles vaccine has no
effect.62
Finally, early identification of HIV infection in children
makes possible close nutritional monitoring, an essential com-
ponent of care for these children. HIV-infected children com-
monly suffer from metabolic and digestive problems that lead
to growth problems, poor weight gain and malnutrition.63 In
' STINE, supra note 5, at 136.
STINE, supra note 5, at 136-37; Medical Management of HIV, supra note 22,
at 520.
11 AIDS INST., MEDICAL EVALUATION, supra note 48, at 6 (Table 4); Medical
Management of HIV, supra note 22, at 520 (Table 5); Burroughs & Edelson, supra
note 19, at 61-62.
" AIDS INST., MEDICAL EVALUATION, supra note 48, at 6 (Table 4); Medical
Management of HIV, supra note 22, at 520 (Table 5); Burroughs & Edelson, supra
note 19, at 62.
61 AIDS INST., MEDICAL EVALUATION, supra note 48, at 6 (Table 4); Medical
Management of HIV, supra note 22, at 520 (Table 5); Monitor Serostatus to Pre-
vent Measles in Vaccinated Children, AIDS ALERT, Jan. 1993, at 8.
62 Medical Management of HIV, supra note 22, at 520; Monitor Serostatus to
Prevent Measles in Vaccinated Children, supra note 61, at 8.
63 AIDS INST., NYSDOH, NUTRITION IN HIV INFECTION 1 (1993) [hereinafter
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turn, these problems may lead to a reduction of a child's func-
tional ability and a diminishment of his or her immunity. 4
Close nutritional monitoring is important to prevent these
problems. In addition, close nutritional monitoring is impor-
tant because HIV-infected children are at a greatly increased
risk of infection from contaminated food. Thus, infected chil-
dren should avoid undercooked eggs, meat and fish and should
avoid unpasteurized milk products." For this reason, parents
of HIV-infected children must be educated on clean prepara-
tion techniques and careful storage of leftovers.66 Utilizing
these precautions greatly diminishes an infected child's risk of
infection from food.
In short, current treatments for HIV-infected children are
of significant benefit to these children. The availability of these
treatments strongly support early identification of HIV infec-
tion in children. Nonetheless, while the medical benefits are
clear, a determination of the appropriateness of mandatory
newborn testing is clouded by complex legal and social issues.
II. CURRENT LAW RELATED TO HIV TESTING
A. Informed Consent
Under the law of every state, a patient must give informed
consent prior to the initiation of any non-emergency medical
procedure.67 The right to medical consent derives from the
common law right to bodily integrity and self-determination."
In New York, Judge Cardozo is credited with first recognizing
such a right in Schloendorff v. Society of New York Hospi-
AIDS INST., NUTRITION]; Burroughs & Edelson, supra note 19, at 62-63.
r4 AIDS INST., NUTRITION, supra note 63, at 1.
rl AIDS INST., NUTRITION, supra note 63, at 5; Burroughs & Edelson, supra
note 19, at 62-63.
6 AIDS INST., NUTRITION, supra note 63, at 5.
67 See 61 AM. JUR. 2D Physicians, Surgeons, and Other Healers § 187 & n.77
(1981). In New York, see N.Y. PUB. HEALTH LAW §§ 2504, 2805-d (McKinney
1993).
6 See Catherine M. V. Barrad, Genetic Information and Property Theory, 87
Nw. U. L. REv. 1037, 1063 (1993); Suzanne Sangree, Control of Childbearing by
HIV-Positive Women: Some Responses to Emerging Legal Policies, 41 BUFF. L. REV.
309, 364 (1993); Sharon N. Perley, Note, From Control Over One's Body to Control
Over One's Body Parts: Extending the Doctrine of Informed Consent, 67 N.Y.U. L.
REV. 335, 338 (1992).
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tals,9 when he wrote: "Every human being of adult years and
sound mind has a right to determine what shall be done with
his [or her] own body."" Consequently, a doctor must disclose
all pertinent information to a patient so that the patient may
knowledgeably choose which course of action is best for him or
her. This right entitles a person to refuse medical treatment
even when that treatment is necessary to preserve a person's
life.71
Currently, thirty states recognize that testing for HIV
infection requires informed consent.7 2 In New York, the legis-
lature enacted an independent article of the Public Health
Law-Article 27-F 7 -- to address HIV testing. Among its re-
quirements, Article 27-F prohibits the performance of an HIV
test without a signed, written statement of consent that in-
cludes at least an explanation of the test, the procedures to be
followed, and the confidentiality of the result.74 In addition,
New York requires a test administrator to provide counseling
to the subject of an HIV test before performing the test. Such
counseling must include information on the nature of the HIV
illness, the methods of transmission of HIV, the potential stig-
matizing effect and discriminatory consequences of a positive
result, and the availability of anonymous testing. 5
69 211 N.Y. 125, 105 N.E. 92 (1914).
70 Id. at 129, 105 N.E. at 93. For similar language in other leading cases, see
Pratt v. Davis, 79 N.E. 562 (Ill. 1906), and Mohr v. Williams, 104 N.W. 12 (Minn.
1905).
"' Sangree, supra note 68, at 365; Perley, supra note 68, at 338-39. In one
case, for example, a Jehovah's Witness who had just given birth by a Caesarean-
section operation was allowed to refuse an essential blood transfusion. Fosmire v.
Nicoleau, 75 N.Y.2d 218, 551 N.E.2d 77, 551 N.Y.S.2d 876 (1990).
72 See Sangree, supra note 68, at 446-47 (Table II; listing statutes in states
requiring informed consent for HIV-related testing).
73 N.Y. PuB. HEALTH LAW §§ 2780-2787 (McKinney Supp. 1993) (effective Feb.
1, 1989). See infra note 236 for the text of § 2782 of Article 27-F.
74 N.Y. PUB. HEALTH LAW § 2781(1)-(2) (McKinney Supp. 1993). For other
states that require written consent, see ALA. CODE § 22-IIA-51 (Supp. 1992); ARIZ.
REV. STAT. ANN. § 36-663 (Supp. 1993); CAL. HEALTH & SAFETY CODE § 199.22
(West 1990); HAW. REV. STAT. § 325-16 (Supp. 1992); ILL. ANN. STAT. ch. 410,
para. 305/4 (Smith-Hurd 1993); LA. REV. STAT. ANN. § 40:1300.13 (West Supp.
1992); MICH. COAIP. LAWs ANN. § 333.5133 (West Supp. 1991); MONT. CODE ANN.
§ 50-16-1007 (1991); PA. STAT. ANN. tit. 35, § 7605 (1993); WIS. STAT. ANN. §
146.025 (West Supp. 1991).
71 N.Y. PuB. HEALTH LAW § 2781(3)-(4) (McKinney Supp. 1993). For other
states that require pre-test counseling, see MICH. COMP. LAWS ANN. § 333.5133
(West Supp. 1991); MONT. CODE ANN. § 50-16-1007(3) (1991); PA. STAT. ANN. tit.
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Although the requirements for informed consent under
Article 27-F are strict, there are exceptions. Informed consent
is not necessary for testing conducted on human body parts
used in transplants or research, testing conducted for the pur-
pose of autopsies, testing conducted in connection with legal
actions in which the physical condition or blood relationship of
a party is in controversy, and testing conducted anonymously
for the purpose of research.76 Generally, the New York courts
have narrowly interpreted these exceptions.77
35, § 7605(b) (1993).
New York also requires post-test counseling or counseling referrals to any
person who tests HIV-positive. Such counseling is provided:
(a) for coping with the emotional consequences of learning the result; (b)
regarding the discrimination problems that disclosure of the result could
cause; (c) for behavior change to prevent transmission or contraction of
HIV infection; (d) to inform such person of available medical treatments;
and (e) regarding the test subject's need to notify his or her contacts.
N.Y. PUB. HEALTH LAW § 2781(5) (McKinney Supp. 1993). For other states that
require post-test counseling, see ALA. CODE § 22-11A-53 (Supp. 1992); FLA. STAT.
ANN. § 381.004 (West Supp. 1993); MICH. COMP. LAWS ANN. § 333.5133 (West
Supp. 1991); MONT. CODE ANN. § 50-16-1007(3) (1991); OHIO REV. CODE ANN. §
3701.242(C) (Baldwin Supp. 1992); PA. STAT. ANN. tit. 35, § 7605(e) (1993).
71 N.Y. PUB. HEALTH LAW § 2781(1), (6) (McKinney 1993). The last exception is
the one that permits the current, blinded newborn testing program. In comparison
to laws in other states, New York State's HIV informed-consent statute has few
exceptions. For example, New York does not allow involuntary testing of prison
inmates, see ALA. CODE § 22-11A-17 (Supp. 1991); CAL. PENAL CODE § 7511 (West
1990); CONN. GEN. STAT. ANN. § 19a-582 (West. Supp. 1993); GA. CODE ANN. § 42-
5-52.1 (1991); KY. REV. STAT. ANN. § 197.055 (Baldwin 1991 & Supp. 1992); MD.
CODE ANN., HEALTH GEN. § 18-338 (1990 & Supp. 1992); R.I. GEN. LAWS § 42-56-
37 (Supp. 1991); TEX. CRIM. PROC. CODE ANN. § 46A.01 (West Supp. 1994); UTAH
CODE ANN. § 64-13-36 (Supp. 1992); persons charged or convicted of assault on
law enforcement officers and firefighters, see ARIz. REV. STAT. ANN. § 16-82-102
(Supp. 1992); CAL. HEALTH & SAFETY CODE § 199.97 (West Supp. 1993); or per-
sons whose bodily fluids have come into contact with those of a health care work-
er, law enforcement officer or firefighter, see WASH. REV. CODE § 70.24.105(2)(h)
(1992); Wis. STAT. ANN. § 146.025(5) (Supp. 1993). In addition, New York does not
allow doctors to test patients without informed consent, as a few states do, when
it is "medically indicated to provide appropriate diagnosis and treatment." See
ARK. CODE ANN. § 20-15-905 (Michie 1993); ILL. ANN. STAT. ch. 410, para. 305/8
(Smith-Hurd 1993).
" See Doe v. Connell, 179 A.D.2d 196, 583 N.Y.S.2d 707 (4th Dep't 1992)
(county court had no authority under Article 27-F to order defendant charged with
rape and sodomy to submit to HIV test and to order disclosure of results to vic-
tim and her husband); In re Harry G., 157 Misc. 2d 959, 960, 599 N.Y.S.2d 425,
426 (Fam. Ct. 1993) (denying application in child abuse proceeding to order person
charged with sexually abusing minor to submit to HIV test; "A Court's power to
order an HIV related test is limited."), affd sub nom. In re Michael "WW", 611
N.Y.S.2d 47 (App. Div. 3d Dep't 1994). For cases before the enactment of Article
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27-F in which courts refused to order parties to be involuntarily tested for HIV,
see Doe v. Roe, 139 Misc. 2d 209, 526 N.Y.S.2d 718 (Sup. Ct. 1988) (showing of
need for HIV test of father in custody action was insufficient where, even if father
had AIDS, such condition would not justify removing children from his custody);
Anne D. v. Raymond D., 139 Misc. 2d 718, 528 N.Y.S.2d 775 (Sup. Ct. 1988)
(husband's mere allegations that wife engaged in extramarital affairs not sufficient
showing to order HIV testing of wife).
Both before and after the enactment of Article 27-F, courts have struggled
with cases involving defendants charged with assault or rape. Before Article 27-F,
courts generally applied a balancing approach to these cases. For example, in
People v. Thomas, 139 Misc. 2d 1072, 529 N.Y.S.2d 429 (County Ct. 1988), a case
involving a defendant charged with rape, the court explained:
Considering the equities of this entire situation, this Court holds and
determines that the victim has a right to know whether she may have
been exposed to the AIDS virus by reason of having been exposed to the
body and sexual fluids of the defendant. This Court finds and determines
that it has inherent discretionary power to order the defendant to submit
to such a blood test simply because it is the intelligent, humane, logical,
and proper course of action under the circumstances. The mental anguish
suffered by the victim knowing that she was forcibly raped and
sodomized by a former inmate of the New York State Department of
Correctional Services is real and continuing, and the intrusion upon de-
fendant of a routine drawing of a blood sample is very minimal and com-
monplace.
Id. at 1074-75, 529 N.Y.S.2d at 431; see also People v. Cook, 143 A.D.2d 486, 532
N.Y.S.2d 940 (3d Dep't 1988).
Although Article 27-F does not provide an exception to informed consent for
the testing of defendants charged with assault or rape, courts nonetheless have
ordered defendants to undergo HIV testing when that defendant communicates his
or her HIV status to the victim of the assault or rape. In those situations, courts
have found that the defendants' HIV stpatus has become a material element of the
crime or has been placed 'in controversy." See In re Anonymous, 156 A.D.2d 1028,
549 N.Y.S.2d 308 (4th Dep't 1989) (affirming county court's order to compel defen-
dant to provide blood sample to prosecutor where defendant was charged with
attempted murder for attempting to infect three police officers with HIV by biting
them), affd, 76 N.Y.2d 766, 559 N.E.2d 670, 559 N.Y.S.2d 976 (1990); People v.
Anonymous, 153 Misc. 2d 436, 582 N.Y.S.2d 350 (County Ct. 1992) (ordering HIV
test of defendant charged with assault who, while trying to avoid arrest, bit a
security guard and a manager of a retail store and told them she was HIV-posi-
tive); People v. Durham, 146 Misc. 2d 913, 553 N.Y.S.2d 944 (Sup. Ct. 1990) (or-
dering HIV test of defendant who raped his victim and afterwards told her that
he had AIDS). Recently, the New York State Assembly introduced a bill that
would amend Article 27-F to allow testing of certain sex offenders. New York
State Assembly Bill No. 9295, 215th Gen. Assembly, 2d Sess. (1994).
For legal commentary on involuntary HIV testing in assault and rape cases,
compare Kimberly A. Harris, Note, Death at First Bite: A Mens Rea Approach in
Determining Criminal Liability for Intentional H1V Transmission, 35 ARIZ. L. REV.
237, 263 (1993) ("AIDS is a new phenomenon and AIDS-related crimes are even
newer. The occasion, and therefore the need, has arisen in the criminal law to
find criminal liability for criminal acts of AIDS transmission. Legislators must
draft new statutes to establish a proper deterrence precedent for HIV carriers who
BROOKLYN LAW REVIEW
B. Confidentiality of Test Results
In addition to strict informed consent requirements for
HIV testing, Article 27-F also includes strong confidentiality
requirements for HIV test results.7' As the New York legisla-
ture has recognized, confidentiality encourages voluntary test-
ing, protects a person's privacy, and limits the risk of discrimi-
nation.79 Besides the protected individual, there are few per-
sons and institutions to whom disclosure of confidential HIV
information is authorized. For example, disclosure is permitted
to attending health care providers, third party reimbursers or
insurance companies authorized by the protected individual to
receive such information, and certain employees of correctional
facilities.8 " If a person discloses confidential HIV information
choose to use the virus to threaten a person's life. The gravity and incurability of
the AIDS virus demands these legislative steps.") and Eisenstat, supra note 14, at
370-71 (a victim's fear of infection added to the trauma suffered as a result of
sexual assault militates in favor of testing sex offenders because a negative result
provides hope for the victim during an emotional crisis) with Paul H. MacDonald,
Note, AIDS, Rape, and the Fourth Amendment: Schemes for Mandatory AIDS Test-
ing of Sex Offenders, 43 VAND. L. REV. 1607 (1990) (questioning the benefit of
involuntarily testing sex offenders) and Lisa Simotas, Note, In Search of A Bal-
ance: AIDS, Rape, and the Special Needs Doctrine, 66 N.Y.U. L. REV. 1881 (1991)
(involuntary testing of sex offenders is unconstitutional). See also Larry Gostin,
The Politics of AIDS: Compulsory State Powers, Public Health, and Civil Liberties,
49 OHIO ST. L.J. 1017 (1989).
Spitting, biting, or splattering blood at a person in anger can be a seri-
ous assault. But prosecutors across the country are viewing the same
behavior among persons with HIV as attempted murder or assault with a
deadly weapon. By viewing assaultive behavior as much more serious
when exhibited by AIDS patients, prosecutors make two fundamental
errors in judgment: they wrongly assume that persons with HIV have a
desire to kill when they behave irresponsibly, and they significantly over-
estimate the danger presented by the behavior.
Id. at 1046.
78 N.Y. PUB. HEALTH LAW § 2782 (McKinney Supp. 1993). See infra note 236
for the text of § 2782, in pertinent part.
7" HIV and AIDS Related Information Act, 1988 N.Y. Laws 584, § 1, reprinted
in N.Y. PUB. HEALTH LAW § 2780 (McKinney Supp. 1993) (historical and statutory
notes).
"I N.Y. PUB. HEALTH LAW § 2782(1) (McKinney Supp. 1993). Other states also
provide exceptions to exposed law enforcement officers, firefighters and health care
workers, see supra note 76, and to victims of sex crimes. See ARIZ. REV. STAT.
ANN. § 16-82-101 (Supp. 1993); CAL. PENAL CODE § 1202.1 (West 1990); COLO.
REV. STAT. ANN. § 18-3-415 (West Supp. 1993); FLA. STAT. ANN. § 960.003 (West
Supp. 1993); GA. CODE ANN. § 17-10-15 (1990 & Supp 1993); IDAHO CODE § 39-
604 (Supp. 1992); IND. CODE ANN. § 35-38-1-10.5 (Burns 1990); KY. REV. STAT.
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in violation of the statutory provisions, New York provides
both civil and criminal penalties."' A violation can result in a
fine of $5000 and, if committed willfully, a misdemeanor pros-
ecution. 2
Unlike the informed consent section of Article 27-F, the
confidentiality section has provisions for the use of discretion-
ary power. Under one provision, a physician may disclose an
infected person's HIV test result to that person's spouse or
sexual partner or hypodermic-needle sharer if the physician
reasonably believes that there exists a significant risk of infec-
tion between the infected person and his or her contact." Un-
der another provision, a court may order a person to disclose
confidential HIV information if the court finds a compelling
need for such action in the adjudication of a criminal or civil
proceeding, or if the court finds that a clear and imminent
danger exists to an individual or the public.'
ANN. § 510.320 (Baldwin Supp. 1992); ME. REV. STAT. ANN. tit. 5, § 19203-E
(West Supp. 1993); MICH. COMP. LAWS ANN. § 333.5129 (West Supp. 1991); MISS.
CODE ANN. § 99-19-203 (Supp. 1993); Mo. REV. STAT. § 191.663 (Supp. 1993); NEV.
REV. STAT. § 209.385 (1992 & Supp. 1993); S.C. CODE ANN. § 16-3-740 (Law. Co-
op. Supp. 1993); S.D. CODIFIED LAWS ANN. § 23A-35B-4 (Supp. 1993); VA. CODE
ANN. § 18.2-62 (Michie Supp. 1993); WASH. REV. CODE § 70.24.340 (1992).
81 N.Y. PUB. HEALTH LAW § 2783 (McKinney 1993). Although there is no ex-
plicit statutory provision granting a protected person a private cause of action
against a person who unlawfully discloses his or her 1HV information, New York
courts have determined that a private action may be maintained. See, e.g., Doe v.
Roe, 190 A.D.2d 463, 599 N.Y.S.2d 350 (4th Dep't 1993). Other states have explic-
itly provided for a private cause of action. See, e.g., ARIZ. REV. STAT. ANN. § 36-
668 (Supp. 1993); DEL. CODE ANN. tit. 16, § 1204 (Supp. 1990); ILL. ANN. STAT.
ch. 410, para. 305/13 (Smith-Hurd 1993).
82 N.Y. PuB. HEALTH LAW § 2783(1)(b), (2) (McKinney Supp. 1993).
83 N.Y. Pun. HEALTH LAW § 2782(4) (McKinney Supp. 1993). This statute also
contains other provisions, including the requirements that a physician encourage
an infected person to reveal his or her test result to a contact personally and that
a physician inform an infected person of the physician's intention to notify the
contact. Id. For other states that have similar provisions, see ARIZ. REV. STAT.
ANN. § 36-664 (Supp. 1993); CAL. HEALTH & SAFETY CODE § 199.22 (West 1990);
HAW. REV. STAT. § 325-101 (Supp. 1992); LA. REV. STAT. ANN. § 40:1300.14(E)(1)(a)
(West Supp. 1992); MICH. CoMP. LAWS ANN. § 333.5131 (West Supp. 1991); MONT.
CODE ANN. § 50-16-1009 (1991); PA. STAT. ANN. tit. 35, § 7609 (1993).
84 N.Y. PuB. HEALTH LAW § 2785(2) (McKinney Supp. 1993).
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C. Applicability of HIV-Related Testing Laws to Mandatory
Newborn Testing
Certainly, mandatory newborn testing violates the in-
formed consent section of Article 27-F as it is now written.
Mandatory newborn testing, however, is unlike any of the
exceptions that currently exist under that section. Therefore,
there is little insight to draw from the current law as it applies
to mandatory newborn testing. One observation is, nonethe-
less, in order. The issues surrounding a mandatory newborn
testing program involve the complex balancing of social, politi-
cal and medical issues, which the legislature is better able to
handle than the courts. It is likely that courts will be deferen-
tial to the legislature's resolution of these controversial issues
and, thus, uphold such a program should it be enacted and
subsequently challenged.85
III. OVERRIDING INFORMED CONSENT
Mandatory. newborn testing implicates parents' rights
under state common law to give informed consent on behalf of
their children. 6 Unlike the right to determine the course of
medical treatment for themselves, however, the parents' right
to determine the course of treatment for children is limited. A
parent may not deprive a child of life-saving treatment. Courts
consistently have allowed the state to intervene when a child's
health is in imminent danger.8 7
Although the courts in some states have restricted the
right to intervene only to those decisions involving life-and-
death situations, New York courts have allowed much broader
See Eisenstat, supra note 14, at 380 (noting judicial deference to involuntary
HIV-related testing statutes in other states).
' Sangree, supra note 68, at 374.
8' In re Storar, 52 N.Y.2d 363, 381, 420 N.E.2d 64, 73, 438 N.Y.S.2d 266, 275
(1981); Elizabeth J. Sher, Note, Choosing for Children: Adjudicating Medical Care
Disputes Between Parents and the State, 58 N.Y.U. L. REV. 157, 162 (1983). For
example, when a child had a malignant growth in her eye that caused blindness
and likely would have killed her if left unattended, the state was allowed to pro-
ceed with the removal of the eye over the parents' objection. In re Vasko, 238
A.D. 128, 263 N.Y.S. 553, 555 (1933).
[Vol. 60: 407
1994] PROPOSAL TO UNBLIND HIV TESTING FOR NEWBORNS 427
intervention."8 The New York approach can be described as
the "beneficial effect" approach. 9 For example, one New York
court allowed an operation to correct the deformity of a child's
right foot.9" The operation was needed not to save the life of
the child, but only to "stabilize the foot and prevent aggrava-
tion and extension of the deformity."91 In granting the opera-
tion over the objection of the father, the court explained:
The physical well being of children is the basis for the moral care,
proper training and guidance. A child who is deprived of the use of
its limb which becomes progressively worse cannot have a sense of
security. It feels itself different from others. It suffers from a sense
of rejection. It cannot take its proper place in the group in which it
lives. To the extent that medical science can correct the deformity or
the limitation of the use of a limb, that service should be accord-
ed.'
In fact, a child's well-being is sufficiently important that it
will, in some circumstances, outweigh a parent's constitutional
rights. For example, in In re Sampson,93 the court ordered a
boy to undergo a dangerous surgical procedure over the reli-
gious objections of his mother. The boy suffered from extensive
neurofibromatosis which had caused a serious deformity of the
right side of his face and neck. Although the boy's disease
could not be cured and the boy's health was in no immediate
threat, the boy's surgeons recommended that he undergo plas-
tic surgery to correct the condition of his face and neck. The
surgeons would not proceed, however, without permission from
the mother to administer blood transfusions to the boy during
the risky operation. The mother, a Jehovah's Witness, believed
that the transfusion of blood was prohibited by the Bible and
refused to consent to such a procedure. In overriding the
mother's religious objections, the court stated:
[Tihe massive deformity of the entire right side of his face and neck
is patently so gross and so disfiguring that it must inevitably exert a
Sher, supra note 87, at 163.
See In re Ray, 95 Misc. 2d 1026, 1029, 408 N.Y.S.2d 737, 739 (1978) ("Court
intervention may be justified not only where there is an emergency, but also
whenever medical intervention will have a beneficial effect."); Sher, supra note 87,
at 163 & n.29.
" In re Rotkowitz, 175 Misc. 948, 25 N.Y.S.2d 624 (1941).
Id. at 951, 25 N.Y.S.2d at 627.
Id. at 950, 25 N.Y.S.2d at 626.
65 Misc. 2d 658, 317 N.Y.S.2d 641 (1970).
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most negative effect upon his personality development, his opportu-
nity for education and later employment and upon every phase of
his relationship with his peers and others.
... [Tihe conclusion is inescapable that the marked facial dis-
figurement from which this boy suffers constitutes such an overrid-
ing limiting factor militating against his future development that
unless some constructive steps are taken to alleviate his condition,
his chances for a normal, useful life are virtually nil. 4
In contrast to Sampson, courts have refused to allow inter-
vention where a child is able to decide for himself or herself
whether to pursue the recommended state treatment. In In re
Seiferth,95 a fourteen-year-old boy had a cleft palate and hare-
lip that could be rectified by surgery. The boy's father imparted
the decision to the boy, who chose not to undergo the opera-
tion. 6 In denying the state's request to intervene, the Seiferth
court considered significant that the boy's consent was neces-
sary for his rehabilitation after the surgery and that his condi-
tion was not urgent or life-threatening.97
Similarly, courts have not been receptive to state interven-
tion where the parent decides a reasonable course of treatment
from among several alternatives. In In re Hotbauer," the par-
ents of an eight-year-old boy who was suffering from Hodgkin's
disease refused to follow the recommendations of the attending
" In re Sampson, 65 Misc. 2d 658, 660, 317 N.Y.S.2d 641, 644 (1970). The
interests of a child outweigh the interests of the mother even when the blood
transfusion must be performed on the mother to save the child. See In re Jamaica
Hosp., 128 Misc. 2d 1006, 491 N.Y.S.2d 898 (1985) (ordering blood transfusion for
mother over her religious objections where transfusion was necessary to save the
life of her mid-term fetus).
"5 309 N.Y. 80, 127 N.E.2d 820, 148 N.Y.S.2d 45 (1955).
96 Id. at 84, 127 N.E.2d at 822, 148 N.Y.S.2d at 47. The court indicated that
the boy probably turned down the operation because his father had inculcated him
with the values of "mental healing." Id.
Seiferth had a strong, three-judge dissent. The dissent argued:
[The boy] is afflicted with a massive harelip and cleft palate which not
only grievously detract from his appearance but seriously impede his
chances for a useful and productive life.... [Niormalcy and happiness,
difficult of attainment under the most propitious conditions, will unques-
tionably be impossible if the disfigurement is not corrected.
Id. at 86-87, 127 N.E.2d at 823-24, 148 N.Y.S.2d at 48-49 (dissenting opinion).
Although Seiferth may clearly be distinguished from cases allowing state interven-
tion, the majority's decision in that case nevertheless was later called into ques-
tion by the Sampson court, which quoted the dissent with approval.
98 47 N.Y.2d 648, 393 N.E.2d 1009, 419 N.Y.S.2d 936 (1979).
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physician to have the child's disease treated by radiation and
chemotherapy. 9 Worried about the harmful effects of these
treatments, they placed him instead under the care of duly
licensed physicians who advocated nutritional and metabolic
therapy.0 0 In deciding the case, the court phrased the inqui-
ry as
whether the parents, once having sought accredited medical assis-
tance and having been made aware of the seriousness of their child's
affliction and the possibility of cure if a certain mode of treatment is
undertaken, have provided for their child a treatment which is rec-
ommended by their physician and which has not been totally reject-
ed by all responsible medical authority."'
Finding that numerous qualified doctors had contributed to the
child's care, that the parents had both serious and justifiable
concerns about the harmful effects of radiation treatments and
chemotherapy, that the nutritional treatment being adminis-
tered to the child was controlling his condition, and that the
parents agreed conventional treatments would be administered
if the child's condition worsened, the court denied the state's
request to intervene.
10 2
These cases reveal that the benefits of newborn testing
provide a sufficient basis to override a parent's informed con-
sent. Currently available treatments improve HIV-infected
newborns' quality and duration of life by preventing infections,
reducing hospitalizations, and improving physical and mental
development.0 3 In addition, the risks associated with these
treatments are low."0 4 These treatments provide benefits that
are surely as important as those derived by correcting the
deformity of a child's foot' 5 or face and neck.10 6 Further-
more, while reasonable alternative choices of treatments exist,
" Id. at 652, 393 N.E.2d at 1011, 419 N.Y.S.2d at 938.
10 Id.
... Id. at 656, 393 N.E.2d at 1014, 419 N.Y.S.2d at 941.
10 Id. at 657-58, 393 N.E.2d at 1014-15, 419 N.Y.S.2d at 941-42.
1 See supra notes 42-66 and accompanying text.
1 Although prophylactic and antiretroviral drugs have toxic side effects, these
drugs are not dangerous as long as the patient is monitored and the drugs discon-
tinued once the effects appear. See STINE, supra note 5, at 133; CDC Guidelines,
supra note 48, at 1638-39 (fatal reaction to TMP-SMX, a popular POP prophylaxis,
occur in less than 1 in 100,000 children).
10. In re Rotkowitz, 75 Misc. 984, 25 N.Y.S.2d 624 (1941).
1 In re Sampson, 65 Misc. 2d 658, 317 N.Y.S.2d 641 (1970).
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if newborns are not tested, they are left with no treatment at
all.
IV. ANALYSIS OF THE NEED, BENEFITS AND COSTS OF
NEWBORN TESTING
A. Need for Mandatory Newborn Testing
Mandatory testing is necessary because data from the New
York State Department of Health ("NYSDOH") shows that vol-
untary testing has been unsuccessful. In 1989, the NYSDOH
introduced the Obstetrical Initiative, a program designed to
expand access to HIV counseling and testing in hospitals state-
wide.0 7 Data collected from this program shows that between
the beginning of August 1990 and the end of March 1992,
16,436 women were counseled to be tested. 1 8 Of this number,
only 6754 women, or 41%, consented to be tested."0 9 Thus,
the program succeeded in testing fewer than one-half of the
women counseled. Furthermore, of the women who consented
to be tested, only 198 were HIV-positive; of those who did not
consent to be tested, only 276 were aware that they were HIV-
positive on admittance."0 Accordingly, these numbers indi-
cate that the program identified approximately 474 potentially
infected newborns."' Yet, according to a New York State
seroprevalence study, about 3280 children were born to sero-
positive mothers during this time."' Therefore, the program
merely identified 15% of the HIV-infected children born in the
state."'
10 AIDS INST., NYSDOH, HIV COUNSELING AND TESTING OF CHILDBEARING
WOMEN: A REPORT OF NEW YORK STATE POLICY AND EXPERIENCE WITH A STATE-
WIDE POST-PARTUM PROGRAM 2 (1993) (the hospitals selected accounted for the
care of 62% of HIV-infected women giving birth).
100 Id.
10 Id. In addition to this number, the data shows that 276 women were aware
that they were HIV-positive on admittance. Id.
110 Cumulative Data on Obstetrical Initiative from NYSDOH (Jan. 1993) (on file
with author).
" Id. Data was unavailable on the exact number of infants born to each HIV-
infected mother. The estimate assumes that one child was born to each HIV-infect-
ed mother.
112 SUBCOMMITTEE REPORT, supra note 22, at 7 (estimate based on data in Ta-
ble 1).
.. This estimate assumes that the perinatal transmission rate of the mothers
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In a more recent NYSDOH study, which gathered data
from July 1993 through September 1993, 120 seropositive
women were identified.1 4 In the same period, state seroprev-
alence data shows that 228 infants were born to seropositive
mothers."5 Therefore, this second study identified about 53%
of the HIV-infected children born in the state. Although the
number of infants identified in this second study was a marked
improvement over the previous one, the number remains unac-
ceptably low."6
Notwithstanding these statistics, the New York State
AIDS Advisory Council recently issued a report advocating
state-wide voluntary testing programs based on a program in
effect at Harlem Hospital."7  While this program has
achieved a 90% test consent rate,"8 the council's recommen-
dation is problematic for two reasons. First, the Harlem Hospi-
tal program appears to be a directive counseling program,"9
and it is unclear that such programs are indeed truly volun-
giving birth at the program hospitals is approximately the same as that of moth-
era giving birth throughout the state.
114 Testing of HIV Positive Women by NYSDOH-Funded Programs, July 1, 1993
to September 30, 1993 (on file with author). This number includes 84 women who
knew their HIV-positive status on hospital admittance, as well as those women
identified by the NYSDOH-funded programs.
115 Id.
11. The percentage may actually be lower than 53% because the study data does
not reveal whether the women who were reported as aware of their seropositive
status on hospital admittance included any of the women identified by the
NYSDOH-funded programs. The New York State AIDS Advisory Council reports
that, through New York State's Obstetrical Initiative and Prenatal Care Assistance
Program, about 46% of HIV-infected pregnant women have learned their HIV sta-
tus prior to delivery. SUBCOMMITrEE REPORT, supra note 22, at 31-32. However,
the council falls to report the estimated number of HIV-infected newborns identi-
fied through these programs. The number given by the council is misleading be-
cause the percentage of women who consent to be tested does not necessarily
correspond to the percentage of infected women and newborns identified by the
tests.
11 SUBCOMMITrEE REPORT, supra note 22, at 32.
118 SUBCOMMITTEE REPORT, supra note 22, at 32.
119 Directive counseling encourages a person to make one choice over others; in
contrast, nondirective counseling simply informs a person of all alternative choices.
STINE, supra note 5, at 334. While the council's report does not provide details of
the Harlem Hospital program, the program has been described as an "aggressive
voluntary program," SUBCOMMITTEE REPORT, supra note 22, at 32, and an "inten-
sive and closely supervised counseling program." Peter Hellman, Suffer the Little
Children: The Rising Storm Over the Law that Keeps HIV-Positive Newborns From
Early AIDS Treatment, NEW YORK, Feb. 21, 1994, at 31.
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tary. For example, in one article describing the Harlem Hospi-
tal program, one author wrote: "If all else fails, counselors may
ask another mother who's already agreed to testing to 'soften
up' the resisting mother with a private chat."12 This type of
"softening up" borders on coercion. Second, as the four-member
dissent to the council's majority position pointed out, there is
no evidence that the Harlem Hospital program could be repli-
cated across the state.12' As the director of Harlem Hospital's
family-care center admitted, when asked whether the program
could be cloned elsewhere, "Like your grandmother's recipe,
the chemistry at our site is very complicated."'22 Given the
questions regarding the Harlem Hospital program and the
poor, state-wide statistics on voluntary testing, mandatory
testing is the only way to identify all HIV-infected infants born
in the state.'23
120 Id.; see also Taunya L. Banks, Women and AIDS-Racism, Sexism, and
Classism, 17 N.Y.U. REV. L. & SOC. CHANGE 351, 375 (1990) (noting that prenatal
directive counseling of pregnant women may be coercive to some women).
121 LOUIS Z. COOPER ET AL., DISSENTING COMMENTS TO THE REPORT OF THE
SUBCOMMITTEE ON NEWBORN SCREENING OF THE AIDS ADVISORY COUNCIL 3 (1994);
Keeping a Baby's HIV Status Secret Puts Privacy Ahead of Infant Health. That's
Crazy., N.Y. NEWSDAY, Mar. 2, 1994, at 48 (questioning the ability to replicate the
Harlem Hospital program state-wide).
122 Hellman, supra note 119, at 31.
12 The method of newborn testing advocated by this Note is universal newborn
testing-that is, testing of all newborns. Another approach that has been suggest-
ed is selective mandatory testing-testing only infants born to women in high-risk
categories. This type of testing presents two problems. First, it will be difficult in
practice to identify those women who are in a high-risk category because it is
unlikely that many of these women will reveal their high-risk behavior. COMMIT-
TEE ON PRENATAL AND NEWBORN SCREENING FOR HIV INFECTION, INSTITUTE OF
MEDICINE, HIV SCREENING OF PREGNANT WOMEN AND NEWBORNS 39 (Leslie M.
Hardy ed., 1991) [hereinafter INSTITUTE OF MEDICINE REPORT]; MAHRUKH BAMJI ET
AL., HIV TESTING AMONG WOMEN AND CHILDREN: VARIABLES ASSOCIATED WITH
ACCEPTING OR DECLINING TESTING-LESSONS FROM AN INNER CITY HOSPITAL 6
(1992) (pre-publication draft on file with author) (in one study, about one-half of
HIV-infected women did not acknowledge previous high-risk behavior). Second,
high-risk testing is discriminatory because the targeted women are mostly from
poor and minority populations. Targeting these populations would unjustly add to
their plight by labeling them as "sources of contagion." Field, supra note 23, at
435; INSTITUTE OF MEDICINE REPORT, supra, at 39.
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B. Benefits of Newborn Testing
As previously discussed, there are a variety of treatments
today that will enhance the duration and quality of life of an
infected child.'24 Therefore, both the CDC and the NYSDOH,
the two governmental bodies that provide the most influence
and leadership on these issues, have recognized that early
diagnosis is critical for treating HIV-infected newborns.'25
Benefits from early diagnosis include the timely adminis-
tration of prophylaxis to prevent deadly opportunistic infec-
tions such as PCP. Other benefits include the timely admin-
istration of antiretroviral therapy and IVIG to improve physi-
cal and mental development and to decrease the incidence of
recurrent bacterial infections and hospitalizations.'26 Early
diagnosis also enables a health care provider to adjust the
immunization schedule to provide an HIV-infected child with
aggressive treatment."' Finally, early diagnosis allows the
implementation of close nutritional monitoring. This monitor-
ing is a crucial component of HIV-infected child care because
nourishment problems are common in HIV-infected children
and, left unattended, can accelerate the breakdown of an in-
fected child's immune system.'28
Early diagnosis also enables newborn participation in
clinical trial programs.129 These programs test the safety and
efficacy of the newest treatments for HIV.3 ' Participation in
these programs provides children with various benefits: first,
children have access to state-of-the-art medicine before it is
generally available; second, children who are not responding
124 See infra notes 42-62 and accompanying text.
1 CDC Guidelines, supra note 48, at 1640 ("an optimal prophylaxis program
will involve identification of HIV-exposed infants as soon as possible so that pro-
phylaxis can be initiated, when indicated, to prevent PCP"); Letter from Nilsa
Gutierrez, supra note 43 at 1 ("The enclosed protocols emphasize early medical
intervention as essential to the improvement of both survival and quality of life.").
126 See supra notes 44-58 and accompanying text.
' See supra notes 59-62 and accompanying text.
1 See supra notes 63-66 and accompanying text.
129 AIDS INST., NYSDOH, EXPERIMENTAL TREATMENTS FOR HIV AND AIDS 3-4
(1993).
13 Clinical trials are divided into three phases. During Phase I of a trial, a
new drug is tested for safety and dose tolerance in patients. After a drug has
been shown to be reasonably safe, it may advance to Phase II and III trials, in
which the efficacy of the drug is tested. Id.
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well to the usual medication have access to alternative medica-
tion; and third, treatments tested in these trials are usually
provided free of charge to the participant.13'
Furthermore, medical science's experience with HIV and
knowledge of the disease are still in the early stages. The first
cases of people diagnosed with AIDS were reported in
1981.132 Since that time, medical science has made great
strides in treatment for both adults and children afflicted with
the disease. Although cures and vaccines have been elu-
sive,' 3 progress has been made in these areas and there is
hope that solutions will be found.13 For example, following
promising results with adult vaccines, several vaccines for
children currently are being tested in national clinical tri-
als.'35 Considering the speed with which progress has been
made and the promise of current experiments, any additional
time a child survives is of great value.
Early diagnosis provides benefits to the mother as well. Al-
... See id.
132 STINE, supra note 5, at xxiv.
' See, e.g., Murray B. Gardner, Acquired Immunodeficiency Syndrome Vaccines,
158 W. J. MED. 296, 296 (1993) (describing that experimental vaccines have pro-
duced mixed results in clinical trials and that these vaccines have been found to
have two shortfalls: they require multiple injections over several months and they
provide only short-lived immunity).
134 See STINE, supra note 5, at 149.
X-ray studies on the HIV proteinase enzyme have allowed for replicating
its three-dimensional structure. This is the opening salvo in what may be
the second front of the therapeutic war on AIDS .... As research pro-
gresses, scientists have found that HIV protease is distinctly different
from other protease enzymes in the body, so a drug that blocks the en-
zyme in HIV probably will not affect normal cells.
Id.; see also Gardner, supra note 133, at 296 (although efficacy of vaccines used to
prevent infection in uninfected people have been disappointing, vaccines used to
delay or prevent onset of disease in infected people have shown promise); HIV
Advance Cited, N.Y. NEWSDAY, Oct. 31, 1993, at 18 (researchers at the Aix-Mar-
seille University in southern France have found a molecule that could stop HIV
from penetrating healthy cells).
135 HIV Vaccines to Be Tested in HIV Positive Children, AIDS WEEKLY, Apr. 5,
1993, at 5. The United States National Institutes of Health announced that three
vaccines are to be administered to children ages one month to 12 years in at least
12 hospitals located nationwide. At least half of the participants will be children
ages two years or younger. Id. "The tests will be used to help researchers deter-
mine whether the vaccines slow the progress of the disease by triggering immuno-
logical responses to HIV in children who are not yet sick." Id. These vaccines
follow on the heels of preliminary trial results of vaccines in adults that show
that they increase the body's immunological response to HIV. Id.
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though the purpose of newborn testing is to identify infected
newborns, such testing also necessarily reveals the seropositive
status of a newborn's mother. While this identification is the
source of many problems associated with newborn testing,"6
it also provides many benefits.
First, identification of a mother's seropositive status en-
ables her to obtain treatment for herself. The benefits from
treatments available to HIV-infected adults are similar to
those available to HIV-infected children.'37  In addition,
adults gain the further benefit that ZDV therapy has been
proven to prolong their survival. 3 ' These treatments not only
benefit the mother, but also indirectly benefit the newborn,
who may depend on her care.
Second, identification of a mother's seropositive status
helps her to make informed decisions about her future family
plans. She may, for example, use the knowledge of her seropos-
itive status to determine whether to give birth to additional
children." 9 She may also use this knowledge to make ar-
rangements for the care of her children, both infected and
uninfected, who survive her."
138 See infra notes 153-62 and accompanying text.
1 See supra notes 48-66 and accompanying text.
1 See supra notes 49-50 and accompanying text.
.. If a woman knows she is HEIV-positive before giving birth, she may elect to
receive ZDV during pregnancy. In a recent study, researchers observed a perinatal
transmission rate of 8% in women who received ZDV during pregnancy as com-
pared to a perinatal transmission rate of 26% in women who received a placebo.
Lawrence K. Altman, In Major Finding, Drug Curbs H.LV. Infection in Newborns,
N.Y. TIMEs, Feb. 21, 1994, at Al, A13; Study: AZT Can Block HIV in Fetus, N.Y.
NEWSDAY, Feb. 21, 1994, at 14. While this new finding highlights the importance
of prenatal counseling and testing of pregnant women, newborn testing remains
important because many women do not use prenatal care. Jim Dwyer, AIDS Ba-
bies Lose in Game of Politics, N.Y. NEWSDAY, Apr. 18, 1994, at A2.
140 The surge in motherless children due to the HIV epidemic has been called
"an unavoidable social catastrophe." JAMA Study Calls Orphans of HIV/AIDS
Epidemic an "Unavoidable Social Catastrophe," INTERGOVERNMENTAL AIDS REP.,
Sept. 1993, at 4 (quoting David Michaels & C. Levine, Estimates of the Number of
Motherless Youth Orphaned by AIDS in the United States, 248 JAMA 3456 (1992)).
By 1995, it is estimated that more than 37,000 children will be left motherless by
the disease. This number could soar to as high as 125,000 by the year 2000. Id.
It is not unreasonable to expect that many of these orphaned children will be
HIV-infected themselves given that many infected children are now surviving into
their teens. See STINE, supra note 5, at 113 ("[W]ith better therapy now available,
some children born with IV are still alive at five, 10 and 12 years old."); Mireya
Navarro, Growing Up in the Shadow of the AIDS Virus, N.Y. TIMES, Mar. 21,
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Finally, HIV-infected mothers benefit from education
about the modes and prevention of HIV transmission. Al-
though studies have shown that the sexual behavior of many
women does not change after they learn of their HIV infection
status," some women do take advantage of this information
by protecting their sexual partners from infection. 4 1
Education about the modes and prevention of HIV trans-
mission also allows a woman to prevent transmission of the
virus to her uninfected children. Although it is widely accepted
in the scientific community that the virus cannot be transmit-
ted by casual contact in the household, precautions must
be taken so that the blood of infected family members does not
come into contact with that of uninfected family members.
Recently, two well-publicized cases of HIV transmission be-
tween siblings raised public concern about the risk of infection
through casual contact.' T This concern is mostly unwarrant-
ed because plausible explanations of transmission exist in both
cases. In one case, the siblings shared a toothbrush and had
bleeding gums;14' and in the other, the siblings shared a
shaving razor.4 1 Therefore, in both cases, the potential for
blood exposure between infected and uninfected siblings exist-
ed. While scientists reassure us that these types of cases are
very rare," 7 they nonetheless underscore the importance of
household caution in preventing the transmission of HIV. A
household may lack such care if its members are unaware of
their HIV infection status.
1993, at 33 ("In New York City, with nearly a quarter of the nation's pediatric
AIDS cases, doctors say they have seen infected children as old as 14. Officials at
the Federal Centers for Disease Control and Prevention say most children infected
from birth now survive beyond age 5.").
141 See Eisenstat, supra note 14, at 341-42 & n.81.
142 See Field, supra note 23, at 413. Furthermore, one cost-benefit analysis con-
cluded that "screening medium- and high-risk women is likely to be cost-beneficial,
even under a wide range of assumptions about program cost and behavioral chang-
es in response to screening." Margaret L. Brandeau et al., Screening Women of
Childbearing Age for Human Immunodeficiency Virus: A Cost-Benefit Analysis, 152
ARCHIVE INTERNAL MED. 2229, 2229 (1992).
1 See, e.g., STINE, supra note 5, at 160-61.
14 Laurie Garrett, HIV Transmitted Between Siblings: Two Child-to-Child Cases
Reported, N.Y. NEWSDAY, Dec. 5, 1993, at 3, 61.
145 Id.
146 Id.
147 Id.
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C. Costs of Newborn Testing
Learning that one is HIV-positive can have enormous
economic, social and personal consequences. For example, one
recent study has estimated that the average cost of treating a
person infected with HIV who has not yet progressed to AIDS
is $10,000 per year.14 The same study estimated that the av-
erage cost of treating a person with AIDS is $38,300 per year
and the estimated lifetime cost of treating such a person totals
$102,000.141 Moreover, because of the need to monitor HIV-
infected children closely, the cost of their treatment is estimat-
ed to exceed that for adults.50 As exorbitant as these costs
are, they are nonetheless expected to rise over time.'5' This
high cost of care is all the more troublesome because most
infected people are from poor communities.'52
In addition to the economic costs, the specter of stigma
and discrimination by the public15 and the potential loss of
personal and family relationships 54 that are associated with
a positive HIV test result continue to be serious concerns for
the HIV-infected individual. Children, because they are often
seen as "innocent victims" of the disease, are less prone to be
stigmatized than adults.'55 Nevertheless, one author has not-
1 Fred J. Hellinger, Forecasts of the Costs of Medical Care for Persons with
HIV 1992-1995, 29 INQUIRY 356, 356 (1992). The study cited the costs in 1991
dollars and accounted for both inpatient care (hospital visits) and outpatient care
(clinical visits, home care and drugs). Id. at 361.
149 Id. at 361.
... INSTITUTE OF MEDICINE REPORT, supra note 123, at 107 n.6; Robert H.
Parrott, Childhood Human Immunodeficiency Virus Infection: The Spectrum of
Costs, 4 J. ACQUIRED IMMUNE DEFICIENCY SYNDROMES 122, 128 (1991).
151 Parrott, supra note 150, at 127.
1.2 See Sangree, supra note 68, at 315; Joelle S. Weiss, Controlling HIV-Positive
Women's Procreative Destiny: A Critical Equal Protection Analysis, 2 CONST. L.J.
643, 649 (1992).
1" Banks, supra note 120, at 370 ("The stigma of a positive HIV antibody
test-loss of employment, insurance, housing, and other economic or social
harm-provides another reason for women who suspect they are infected with HIV
to avoid routine prenatal screening."). For a discussion of the public response to
AIDS and HIV, see generally STINE, supra note 5, at 345-52 (discussing how fear
and misconceptions have fueled discrimination against HIV-infected people).
11 Field, supra note 23, at 410.
.. The stigma attached to HIV infection and AIDS is thought to arise, in part,
from a public association of the infection with homosexuality, promiscuity or drug
abuse, and the attendant public disapproval of these behaviors. J. David Butts,
HIV/AIDS-Related Information and the Rule of Confidentiality: Can We Accept
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ed that "there is no vaccination against discrimination, even
for the youngest and most helpless of those with HIV dis-
ease.""6 For example, children have been barred from attend-
ing public schools because of their HIV infection.'57 Moreover,
any discrimination that HIV-infected mothers suffer also ad-
versely affects their children.5 '
Finally, learning that one is HIV-positive can cause a
great deal of psychological distress.'59 This distress may be
caused by a number of factors. First, a person is compelled "to
confront the prospect of a painful and ultimately fatal dis-
ease."6 ° Second, a person is forced to confront the large at-
tendant economic and social costs of the disease. Third, not-
withstanding confidentiality laws, a person may live in fear of
unauthorized disclosures.' The stress caused by these fac-
tors is dangerous because it may contribute to the acceleration
of the disease.'62
D. Balancing Needs, Benefits and Costs
Although there are potentially significant costs associated
with newborn testing, these costs are manageable. For exam-
Exceptions?, 40 MED. TRIAL TECH. Q. 1, 13 (1993). Since children are incapable of
these behaviors, they escape these negative perceptions.
16 Hunter, supra note 8, at 24-25.
17 STINE, supra note 5, at 347.
158 HIV Infection, Pregnant Women, and Newborns, supra note 42, at 2418-19
("[Niewborns and their mothers are a family unit; when HIV-infected mothers
experience social or institutional discrimination, their infants suffer as well.").
169 Field, supra note 23, at 411 n.33.
1 Eisenstat, supra note 14, at 365; see Field, supra note 23, at 411 (noting
some people are afraid to face a terrible disease).
161 See Field, supra note 23, at 409 ("Even in places where, in theory, a test
would be confidential, the reality may be that it is difficult to maintain total confi-
dentiality once a person is found to be HIV positive."). In addition, some states
also have exceptions to confidentiality laws. For example, both Arkansas and Mis-
souri require a person who knows her seropositive status to inform her health
care provider prior to receiving care. Id. at 410 & n.30. Furthermore, New York
allows a doctor to reveal a person's seropositive status to the person's spouse,
sexual partner or intravenous-needle sharer. See supra note 83 and accompanying
text.
16 Michael L. Closen, Mandatory Disclosure of HIV Blood Test Results to the
Individuals Tested: A Matter of Personal Choice Neglected, 22 LOY. U. Cai. L.J.
445, 464 (1991) ("[S]tress may itself be a factor contributing to a decline of the
immune system and to the onset of symptoms of AIDS in those who are HIV-
infected.").
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ple, the economic burden of HIV-related treatments is current-
ly eased by state health care programs, federal funding and
Medicaid insurance.113  Opponents of mandatory newborn
testing have noted, however, that these programs cannot guar-
antee treatment to all mothers and newborns identified
through testing.'" They have argued, therefore, that unless
treatment is available to all, mandatory testing is useless."5
This argument falls short on several grounds. First, a lack of
resources is problematic for voluntary as well as for mandatory
testing. Thus, an argument that mandatory testing should not
be implemented unless guaranteed resources exist is an argu-
ment that all testing should not be implemented unless such
resources exist.'66 In addition, even though it is possible that
the care received by some mothers and newborns identified
through mandatory testing will not be completely adequate,
the treatment they do receive is better than no treatment at
all. Finally, the New York State Assembly has shown that it is
committed to improving and expanding health services for
HIV-infected children and their families.'67 The current ver-
sion of Assemblywoman Mayersohn's bill, for example, appro-
priates five million dollars to enhance services for HlIV-infected
families.1
68
" See STINE, supra note 5, at 374-90; INSTITUTE OF MEDICINE REPORT, supra
note 123, at 106-09 (81% of children and 43% of adults hospitalized with AIDS in
New York were covered by Medicaid).
" Elizabeth Cooper et al., Pregnancy and HIV, 327 NEW ENG. J. MED. 645,
645-46 (1992) (correspondence); Field, supra note 23, at 413; Hunter, supra note 8,
at 25.
1" Cooper et al., supra note 164, at 645-47; Field, supra note 23, at 413; Hunt-
er, supra note 8, at 25.
' In the context of voluntary testing, it has been recognized that the identifi-
cation of HIV infection in pregnant women and newborns is sufficiently important
to proceed with programs of prenatal and newborn testing notwithstanding the
lack of adequate resources. See INSTITUTE OF MEDICINE REPORT, supra note 123.
The committee decries the inherent inadequacies in the current health
services and financing system and recognizes that prenatal HIV screening
may identify more women and children who need care than the system
can currently accommodate. Nevertheless, it believes that the benefits of
screening pregnant women for HIV infection in high-prevalence areas are
sufficient to justify proceeding with program implementation, even though
the present health and social services infrastructure may not be com-
pletely adequate.
Id. at 5-6.
1 New York State's allocation of funds for HIV and AIDS care is one of the
highest in the nation. See STINE, supra note 5, at 377.
16 New York Assembly Bill No. 6747-C, 215th Gen. Assembly, 2d Sess. (1994).
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Another economic argument often leveled against manda-
tory testing is that it is not cost-effective. One often-cited ex-
ample of the inefficiency of mandatory testing is the case of a
1987 Illinois marriage license law requiring applicants to be
tested for HIV before a license could be issued.' This law
was eventually repealed because it identified only one positive
person for every 7000 people tested, resulting in a program
cost of nearly $243,000 for each person identified.7 ° Although
some have argued that even this high price was cost-effec-
tive,' analogies between the Illinois law and New York's
mandatory newborn testing bill are inappropriate for several
reasons.
First, Illinois's seroprevalence rate (the number of people
infected with HIV per 1000) is much lower than that in New
York.72 Second, the mobility of marriage applicants in Illi-
nois was probably a major source of the poor identification rate
of the state's testing program. 3  Since Illinois's
seroprevalence rate suggests that more people should have
been identified, a reasonable explanation for the poor identifi-
cation rate is that high-risk couples not wishing to be identi-
fied obtained their marriage licenses from other states. In con-
trast, the mobility of pregnant women is much more limited
than that of marriage applicants. It is unlikely that women
will move out of state to give birth. Lastly, while Illinois's law
implemented a new testing procedure, anonymous newborn
testing already exists in New York. Thus, mandatory newborn
testing will not incur the costs of starting a completely new
procedure in the state. 74
Of course, even the increased allocation of funds can not eliminate all problems in
health care access for affected families. See SUBCOMMITTEE REPORT, supra note 22,
at 21-22. But it would be unreasonable to demand that all health care service
problems be resolved before proceeding with a necessary step in the care of HIV-
infected infants and their families.
Eisenstat, supra note 14, at 351; Sangree, supra note 68, at 388 n.328.
170 Eisenstat, supra note 14, at 351.
171 STINE, supra note 5, at 311 (citing comments of one proponent who stated
that if identifying one HIV-infected person prevented the birth of one HIV-infected
child, the state could save more than $100,000 in life-time medical costs for the
HIV-infected child).
172 Cf CDC SURVEILLANCE, supra note 21, at 3 (Table 1) (the cumulative cases
of AIDS reported to the CDC through June 1993 was 59,312 for New York and
9880 for Illinois).
17. See Eisenstat, supra note 14, at 354.
1 Mandatory newborn testing will require that some modifications be made to
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Although the risk of stigma and discrimination is a serious
concern, this risk is considerably minimized by the strict confi-
dentiality laws in New York State. While some critics have
argued that unauthorized disclosures are inevitable,"5 the
risk of such disclosures is not likely to be a major problem
because of both the medical community's excellent history of
handling confidential information 6 and the civil and crimi-
nal penalties associated with violations of the confidentiality
laws.' Furthermore, it is unlikely, as some critics have ar-
gued, that the fear of stigma and discrimination will drive
women away from health care institutions or cause them to
abandon their infected children. As critics of mandatory new-
born testing admit, most mothers are very caring and will take
the necessary steps to ensure the well-being of their chil-
dren.' In fact, in the long run, mandatory testing may "di-
lute some of the stigma attached to positive test results by
demonstrating that the problem is not restricted to a small
segment of the population" but occurs in low-risk and non-
minority groups as well.'79
Finally, it must be noted that, in the case of a mother who
gives birth to an HIV-infected newborn, the reality is that she
the current testing procedure. For example, newer, more accurate tests, like PCR,
will need to be implemented. In addition, a procedure to contact parents after
hospital discharge will need to be implemented. SUBCOMMITTEE REPORT, supra note
22, at 30-31. While these will add cost to the current anonymous newborn testing
program, these modifications are necessary for both mandatory and voluntary test-
ing programs.
176 See supra note 161 and accompanying text.
.7 Telephone Interview with Dr. Louis Z. Cooper, Director of Pediatric Service,
St. Luke's-Roosevelt Hospital Center, New York, NY (Oct. 18, 1993).
17 See supra notes 81-82 and accompanying text.
178 Elizabeth B. Cooper, When Being Ill is Illegal: Women and the
Criminalization of HIV, 22 HEALTH/PAC BULL. 10, 12 (1992) ([T]here is every
indication that seropositive women, like other women tend to put the well-being of
their children ahead of all other concerns they may have."); Catherine A. Lynch et
al., Don't Test Newborns for AIDS, N.Y. NEWSDAY, May 19, 1991, at 37 (letter to
the editor) ("Women are not their children's enemies, nor are they the obstacles
blocking their children's access to health care. In fact, women are more likely to
bring their children in for care than to get care for themselves."). Advocates of
mandatory newborn testing also share these views. PREVENTABLE CRISIS, supra
note 2, at 34 ("[Ilt has been [the Association to Benefit Children's] experience that
when a woman learns that she and her child are HIV-positive, the mother re-
sponds in an affectionate and caring manner towards her child.").
,"9 INSTITUTE OF MEDICINE REPORT, supra note 123, at 86-88 (discussing univer-
sal screening).
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is likely to learn of her and her newborn's HIV status in short
order even if she decides not to test her child. Without treat-
ment, the probability that an HIV-infected infant will develop
an opportunistic infection within the first year is great." At
that point, the mother may be overwhelmed by the ensuing
situation. She not only will be forced to deal with the sudden
revelation of her and her infant's HIV status, but will be forced
to deal with her infant's serious HIV-related illness (and possi-
bly her own), as well as the realization that this illness might
have been prevented.
In sum, the analysis shows that the case for mandatory
newborn testing is a strong one. Both the need and the bene-
fits of mandatory testing are great. In addition, whether or not
a mother consents to test herself or her child, the high risk of
opportunistic infection within the first year of life for a
perinatally infected child means that the mother will be forced
to face her and her infant's infection status sooner rather than
later. Furthermore, the potential costs of testing have been
properly addressed through funding and strict confidentiality
laws. While these measures cannot eliminate all problems,
they provide a solid foundation upon which Assemblywoman
Mayersohn's recently proposed bill may build.
V. CONSTITUTIONAL ISSUES
The New York State AIDS Advisory Council and various
commentators and have raised questions concerning the consti-
tutionality of mandatory newborn testing.'8 ' The following
,8 INSTITUTE OF MEDICINE REPORT, supra note 123, at 77 ("[C]hildren with
perinatally acquired infection most often develop signs and symptoms of disease
within the first year of life, although the true median age at diagnosis is probably
closer to two years."); Burroughs & Edelson, supra note 19, at 46 ("The mean age
of diagnosis of perinatally infected children is 17 months."); Gwendolyn B. Scott et
al., Survival in Children with Perinatally Acquired Human Immunodeficiency Virus
Type 1 Infection, 321 NEW ENG. J. MED. 1791, 1791 (1989) ("The children present-
ed with symptomatic disease at a median age of eight months; only 21 percent
presented after the age of two years .... [Miost become symptomatic before one
year of age."); see supra notes 45-48 and accompanying text (noting that half of all
perinatally infected children who contracted PCP developed the infection between
three and six months of age).
181 SUBCOMMITEE REPORT, supra note 22, at 25-26 (possible equal protection
and right to privacy violations); John M. Naber & David R. Johnson, Mandatory
H1V Testing Issues in State Newborn Screening Programs, 7 J.L. & HEALTH 55
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analysis addresses Fourth Amendment, equal protection and
privacy issues implicated by mandatory newborn testing.
A. Fourth Amendment
Today, it is well-established that a blood test is a search
within the meaning of the Fourth Amendment.'82 Thus, man-
datory HIV testing of newborns could be challenged on Fourth
Amendment grounds."s Such a challenge most likely would
be unsuccessful because mandatory newborn testing satisfies
the requirements of the Fourth Amendment special-needs
doctrine.
The Fourth Amendment states that "[tihe right of the
people to be secure in their persons, houses, papers and effects,
against unreasonable searches and seizures shall not be violat-
ed."" 4 The purpose of this amendment is to "guarantee[ ] the
privacy, dignity, and security of persons against certain arbi-
trary and invasive acts by officers of the Government or those
acting at their direction."'85 To guard against these types of
acts, most government searches require a warrant issued by a
judge upon probable cause to satisfy the Fourth Amend-
ment. 8' However, the Supreme Court of the United States
has recognized an exception to this general rule when "special
(1992-1993) (possible violation of right to privacy); Sangree, supra note 68 (Fourth
Amendment violation for mandatory testing of pregnant women and newborns and
Fourteenth Amendment violation for mandatory testing of pregnant women); Kevin
J. Cumin, Note, Newborn HIV Screening and New York Assembly Bill No. 6747-B:
Privacy and Equal Protection of Pregnant Women, 21 FORDHAM URB. L.J. 857
(1994) (violation of privacy and equal protection).
1" Skinner v. Railway Labor Executives' Ass'n, 489 U.S. 602, 616 (1989);
Schmerber v. California, 384 U.S. 757, 767-68 (1966).
183 SUBCOMMITEE REPORT, supra note 22, at 26; see also Anonymous Fireman
v. City of Willoughby, 779 F. Supp. 402, 415 (N.D. Ohio 1991) ("HIV testing on
blood already drawn from public employees as part of an annual physical examina-
tion constitutes an intrusion and a search and seizure within the meaning of the
Fourth Amendment."); Sangree, supra note 68, at 435-36 ("Fourth Amendment
rights would also be implicated by the type of laboratory analysis performed on
the blood [sample taken from a pregnant woman's umbilical cord or from her
newborn child]. Absent specific or implied consent to an HIV antibody test, an
HIV analysis of a lawfully-extracted blood sample would itself invoke Fourth
Amendment protections.").
184 U.S. CONST. amend. IV.
,,5 Skinner, 489 U.S. at 613-14; see also Delaware v. Prouse, 440 U.S. 648, 653-
54 (1979); Camara v. Municipal Court, 387 U.S. 523, 528 (1967).
1'8 See, e.g., Skinner, 489 U.S. at 619.
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needs, beyond the normal need for law enforcement, make the
warrant and probable-cause requirement impractical."8 7
The principal case setting forth the special-needs doctrine
is Skinner v. Railway Labor Executives' Ass'n.' Skinner in-
volved regulations promulgated by the Federal Railroad Ad-
ministration ("FRA") requiring alcohol and drug tests for rail-
road employees who were involved in train accidents or vio-
lated safety rules."8 9 The purpose of the FRA regulations was
not to promote the needs of law enforcement, but "'to prevent
accidents and casualties in railroad operations that result from
impairment of employees by alcohol or drugs.""'  Because it
was not associated with police or criminal functions, this need
triggered a balancing test of "governmental and privacy inter-
ests to assess the practicality of the warrant and probable-
cause requirements in the particular context."9 '
The Supreme Court found that a warrant and probable-
cause requirement were unnecessary. The Court weighed the
societal cost of not requiring a warrant-and, therefore, not
having a neutral magistrate present to protect the privacy
interests of citizens-against the likelihood of frustrating the
government's purposes if a warrant were required.'92 Because
the FRA testing program demanded little discretion on the
part of administrators of the program, the Court found that a
neutral magistrate would have very few facts to evaluate.
Accordingly, the detriment caused to privacy interests by not
requiring a warrant was small.'9' The Court also found that
the delay in obtaining a warrant could result in the disappear-
ance of alcohol and drug traces from a person's body and that
the imposition of warrant requirements on railroad administra-
17 Id. (quoting Griffin v. Wisconsin, 483 U.S. 868, 873 (1987)).
188 489 U.S. 602 (1989). A companion case to Skinner, decided on the same day,
is National Treasury Employees Union v. Von Raab, 489 U.S. 656 (1989).
1 Skinner, 489 U.S. at 606.
19o Id. at 620-21 (quoting 49 C.F.R. § 219.1(a) (1987)).
191 Id. at 619. Other cases that have triggered a special-need analysis include
National Treasury Employees Union, 489 U.S. at 656 (drug-testing of Custom Ser-
vice employees); Griffin v. Wisconsin, 483 U.S. 868 (1987) (search of a
probationer's house); O'Conner v. Ortega, 480 U.S. 709 (1987) (work-related
searches of government employees' desks and offices); New Jersey v. T.L.O., 469
U.S. 325 (1965) (search of student's purse by school officials).
19 Skinner, 489 U.S. at 622-24.
9 Id. at 622.
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tors unfamiliar with such requirements would be burdensome.
These factors worked to frustrate and binder the government's
purposes.' 9 Therefore, since the privacy interests were not
harmed by eliminating the warrant and the government's
purposes were frustrated by requiring one, elimination of the
warrant requirement was reasonable under the circumstanc-
es.
195
The Supreme Court also found that neither probable cause
nor individualized suspicion (a lesser showing of cause) was
essential in this case. 9 Again, the Court conducted a balanc-
ing test of privacy interests against governmental purposes. On
the one hand, the Court found that the railroad employees'
privacy interests were minimal because they were tested using
nonintrusive methods 97 and worked in a highly regulated
industry.'98 Correspondingly, the government's interest in
protecting public safety by identifying impaired employees was
great. 9 9 Under these circumstances, the Court concluded that
a warrantless search, conducted without probable cause or
individualized suspicion, was reasonable.
Applying the Skinner analysis to mandatory HIV testing of
newborns demonstrates that mandatory newborn testing is a
constitutional special-needs search. Initially, it is clear that the
purpose of mandatory HIV testing of newborns is to protect the
health of infected newborns, not to serve law enforcement or
criminal prosecution goals. Thus, newborn testing passes the
first hurdle of the Supreme Court's Skinner test. Next, a bal-
ancing of governmental interests against privacy interests
demonstrates that the requirement of a warrant supported by
' Id. at 623.
1 Id. at 624.
19 Id. at 624-33.
..7 Skinner, 489 U.S. at 624-27. Testing was conducted using blood, breath and
urine tests. Id. The Court found that blood tests are commonplace and "'involve[ ]
virtually no risk, trauma, or pain." Id. at 625 (quoting Schmerber v. California,
384 U.S. 757, 771 (1966)). Similarly, breath tests "do not require piercing of the
skin and may be conducted safely outside a hospital environment and with a mini-
mum of inconvenience or embarrassment." Id. In contrast, the Court was hesitant
to find that urine tests implicated minimal privacy concerns. Nonetheless, because
the FRA procedures required the urine tests to be conducted in a medical environ-
ment without direct observation, the Court found these tests to be noninvasive as
well. Id. at 626-27.
198 Id. at 627-28.
19 Id. at 628-29.
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probable cause is impractical for the purposes of mandatory
newborn testing. Like the administration of alcohol and drug
tests to railroad employees in Skinner, the administration of
HIV tests to newborns requires little or no discretion. There-
fore, the value of a warrant and a neutral magistrate's case-by-
case evaluation would be small in this situation. In addition,
the requirement of a warrant would burden hospital personnel
charged with administering the tests because, like the railroad
administrators in Skinner, these personnel are unfamiliar with
warrant procedures. Furthermore, in the context of newborn
testing, hospital personnel would be burdened with a great
many warrant applications. Therefore, under the circumstanc-
es, a warrant requirement would be impractical.
Likewise, it is reasonable to dispense with the require-
ments of probable cause and individualized suspicion. The
privacy interests of the mothers and newborns in their HIV
test results are minimal because they are protected by strict
confidentiality laws, which provide for both criminal and civil
penalties."0 Furthermore, the state has a strong interest in
protecting the health of its HIV-infected newborns. Without
testing for the virus, HIV-infected newborns are not able to
take advantage of all the beneficial treatments available to
them today. Thus, warrantless, suspicionless newborn testing
is a constitutional Fourth Amendment search.
B. Equal Protection
Mandatory HIV testing of newborns raises concerns about
discrimination against minority women,20 ' as currently these
women are disproportionately affected by HIV. Nationally,
almost three-quarters of all women with AIDS are black or
Hispanic.0 2 This percentage increases to as high as 84% in
high-prevalence urban areas.0 '
20" See supra notes 78-84 and accompanying text. For a more complete balanc-
ing of interests, see supra notes 163-80.
201 See SUBCOMMITTEE REPORT, supra note 22, at 25-26.
202 INSTITUTE OF MEDICINE REPORT, supra note 123, at 14 (52% of women with
AIDS were black, 20% were Hispanic and 27% were white); Sangree, supra note
68, at 315 n.17 ("Over 72% of U.S. women with HIV are Black and or Hispanic.");
Weiss, supra note 152, at 649 n.28 (black women comprise 53% and Hispanic
women comprise 21% of women with AIDS in the United States).
203 NEw YORK CITY DEP'T OF HEALTH, AIDS SURVEILLANCE UPDATE, Oct. 1992,
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While these statistics clearly show a disproportionate
impact on minority women, this showing is not sufficient by
itself to establish an equal protection violation.0 4 The key
issue in an equal protection analysis is whether the law has a
discriminatory intent. Disproportionate impact is only one
factor in determining this question."5 Arguably, minority
women could claim that the disproportionate impact of new-
born testing should be viewed in light of previous health laws
that have adversely affected them. For example, one commen-
tator has written:
The long history of reproductive coercion of poor women, wom-
en of color and disabled women-groups currently disproportionately
affected by HIV-is perhaps the most powerful indication that HIV-
positive women are likely targets for control....
Doubt is cast on the professed altruism and wisdom of involun-
tary control of HIV-positive women when such potential control is
viewed in light of the history of eugenics and the more recent co-
erced sterilizations of poor women, disabled women, and women of
color.2"6
This argument is likely to fail. Prior laws that sought to inter-
fere directly with a woman's procreative decisions are not rele-
vant to mandatory newborn testing because such testing occurs
after birth and does not interfere with a woman's procreative
choices. To the extent that such testing plays a role in a
woman's decision regarding whether to bear a child, it is one of
at 6 (black women comprised 51%, Hispanic women comprised 33%, and white
women comprised 14% of women with AIDS in New York City).
2' Mobile v. Bolden, 446 U.S. 55 (1980) (no equal protection violation notwith-
standing that city's at-large voting scheme was shown to dilute blacks' voting
strength); Washington v. Davis, 426 U.S. 229, 239 (1976) (no equal protection
violation where four times as many blacks than whites failed an employment ex-
amination: "our cases have not embraced the proposition that a law or other offi-
cial act, without regard to whether it reflects a racially discriminatory purpose, is
unconstitutional solely because it has a racially disproportionate impact"); Wright
v. Rockefeller, 376 U.S. 52 (1964) (no equal protection violation in irregularly
drawn district lines, even though the challenged districts were made up predomi-
nately of whites).
2" See Washington, 426 U.S. at 242 ("Necessarily, an invidious discriminatory
purpose may often be inferred from the totality of the relevant facts, including the
fact, if it is true, that the law bears more heavily on one race than another.").
2" Sangree, supra note 68, at 332; see also Hunter, supra note 8, at 17 (ex-
pressing suspicion about motivation for mandatory testing of newborns given the
government's lack of zeal in insuring the health of babies in minority communi-
ties).
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the many costs and responsibilities that a woman must weigh
in making a decision regarding childbirth. In short, the sole
purpose of mandatory newborn testing is to identify and to
treat HIV-infected newborns. There is no indication of a legis-
lative intent to discriminate against minority women and thus
no violation of equal protection.
C. Right to Privacy
In Whalen v. Roe,0 7 the Supreme Court held that the
Fourteenth Amendment provides for the protection of two
different kinds of privacy: "One is the individual interest in
avoiding disclosure of personal matters, and another is the
interest in independence in making certain kinds of important
decisions.""' The former interest is commonly referred to as
a person's confidentiality interest and the latter as a person's
autonomy interest."9 Mandatory newborn testing violates
neither interest.
The confidentiality strand of privacy was established by
the Court in Whalen and Nixon v. Administrator of General
Services,"' each decided in the same term. Whalen involved a
New York State statute that required pharmacists to file a
form with the State Health Department identifying the pre-
scribing physician, the dispensing pharmacy, the drug and
dosage, and the patient's name any time the pharmacist dis-
pensed a drug classified as dangerous.211 The purpose of the
law was to prevent potential abuse in prescribing and dispens-
ing drugs such as opium and cocaine." 2 The Health Depart-
ment stored the data retrieved from the forms in a central
computer system, which was protected by tight security mea-
sures and to which only a limited number of department em-
20 429 U.S. 589 (1977).
208 Id. at 599-600 (footnote omitted).
20 See Doe v. City of New York, 15 F.3d 264, 267 (2d Cir. 1994) ("There is,
therefore, a recognized constitutional right to privacy in personal information. More
precisely, this right to privacy can be characterized as a right to 'confidentiality,'
to distinguish it from the right to autonomy and independence in decision-making
for personal matters also recognized in Whalen.").
210 433 U.S. 425 (1977).
... Whalen v. Roe, 429 U.S. 589, 592 (1977).
212 Id. at 592-93.
[Vol. 60: 407
19941 PROPOSAL TO UNBLIND HIV TESTING FOR NEWBORNS 449
ployees had access.213 In addition, the statute prohibited pub-
lic disclosure of the data and provided both criminal and civil
penalties for violations.214 In rejecting the 'confidentiality
challenge to the statute, the Supreme Court first found that
the security provisions of the statute provided adequate protec-
tion from public disclosure of the data.215 Addressing the dis-
closure to the Health Department, the Court next explained:
[D]isclosures of private medical information to doctors, to hospital
personnel, to insurance companies, and to public health agencies are
often an essential part of modem medical practice even when the
disclosure may reflect unfavorably on the character of the patient.
Requiring such disclosures to representatives of the State having
responsibility for the health of the community does not automatical-
ly amount to an impermissible invasion of privacy.
16
The Court thus found no invasion of the confidentiality inter-
est.
217
In Nixon, the issue before the Court was whether an act of
Congress directing the Administrator of General Services to
take custody of President Nixon's papers and tape recordings,
screen them, and allow public access to the non-private por-
tions violated the president's right to privacy.218 The Court
found that "any intrusion must be weighed against the public
interest in subjecting the Presidential materials of appellant's
administration to archival screening."21 9 Because the act con-
tained provisions "aimed at preventing undue dissemination of
private materials" and mandated the return of private papers
and recordings to the president, the Court held that no consti-
tutional privacy interest was violated.220
Although it has been years since the Supreme Court decid-
ed Whalen and Nixon, the scope of the confidentiality interest
2" Id. at 593-94.
214 Id. at 594-95.
215 Id. at 601.
21' Whalen, 429 U.S. at 602.
21. Id. at 603-04.
21' Nixon v. Administrator of Gen. Servs., 433 U.S. 425, 429 (1977). In Nixon,
the President based his challenge on the First, Fourth and Fifth Amendments. Id.
at 455. Nonetheless, the Court's decision relied in part on Whalen, which grounded
its analysis in the Fourteenth Amendment. Id. at 457. See Whalen, 429 U.S. at
603-04.
219 Nixon, 433 U.S. at 458.
2." Id. at 458-59.
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articulated in those cases remains unclear. The Supreme Court
has not addressed confidentiality since then and, in the inter-
im, the courts of appeals have divided on their interpretation
of the two cases. At least four circuits-the Second, Third,
Fifth and Ninth-have recognized a right to confidentiality.22'
Relying on language in Nixon, these circuits have balanced the
public interest served by an intrusion against the harm to an
individual's privacy caused by that intrusion.2 In contrast,
the Sixth Circuit has explicitly rejected a general right to confi-
dentiality,223 and the District of Columbia Circuit has ques-
tioned the scope and basis of such a right. 4
Regardless of how Whalen or Nixon are interpreted, man-
datory newborn testing does not violate the confidentiality
strand of privacy. Under a broad interpretation as dictated by
the Second, Third, Fifth and Ninth Circuits, a general balanc-
ing of interests, as discussed above, weighs in favor of manda-
tory newborn testing. 5 Under a narrower interpretation,
221 See Doe v. City of New York, 15 F.3d 264 (2d Cir. 1994); Thorne v. City of
El Segundo, 726 F.2d 459 (9th Cir. 1983), cert. denied, 469 U.S. 979 (1984); Unit-
ed States v. Westinghouse, 638 F.2d 570 (3d Cir. 1980); Plante v. Gonzalez, 575
F.2d 1119 (5th Cir. 1978), cert. denied, 439 U.S. 1129 (1979).
See, e.g., Westinghouse, 638 F.2d at 578-80.
's Doe v. Wigginton, 21 F.3d 733 (6th Cir. 1994); J.P. v. DeSanti, 653 F.2d
1080 (6th Cir. 1981).
Absent a clear indication from the Supreme Court we will not con-
strue isolated statements in Whalen and Nixon more broadly than their
context allows to recognize a general constitutional right to have disclo-
sure of private information measured against the need for disclosure.
Analytically we are unable to see how such a constitutional right of pri-
vacy can be restricted to anything less than the general "right to be let
alone" .... "Virtually every governmental action interferes with personal
privacy to some degree." . . . [The Framers of the Constitution] cannot
have intended that the federal courts become involved in an inquiry [so]
broad-balancing almost every act of government, both state and federal,
against its intrusion on a concept so vague, undefinable, and all-encom-
passing as individual privacy.
Id. at 1089-90 (citations omitted).
"4 National Fed'n of Fed. Employees v. Greenberg, 983 F.2d 286 (D.C. Cir.
1993) ("When we return to Whalen and look behind the Supreme Court's general
remark, . . . we find ambiguity. What 'individual interests' receive protection from
disclosure? . . . What 'personal information' and disclosure to whom? . .. [What
are the provisions in the Constitution that are said to confer [such protection]?").
22 See supra notes 163-80 and accompanying text. Moreover, both Whalen and
Nixon indicate that limited disclosure to appropriate government or medical per-
sonnel supported by strong security provisions will weigh heavily in favor of a
finding of no constitutional violation of privacy. See Nixon v. Administrator of Gen.
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such a balancing may not be necessary to determine the consti-
tutionality of mandatory newborn testing. The decisions of the
Sixth Circuit and the District of Columbia Circuit raise a valid
question as to what kind of disclosure will trigger a constitu-
tional analysis in the first place. 6 Whalen involved disclo-
sures to a limited number of governmental employees and
medical personnel, while Nixon concerned only governmental
employees. In both cases, the Supreme Court found that no
constitutional violation had occurred. Consequently, one inter-
pretation of these decisions is that a disclosure of private infor-
mation must be public, or at least sufficiently widely dissemi-
nated, to invoke constitutional protection. Under this interpre-
tation, mandatory newborn testing would not trigger the right
to confidentiality of a mother or her newborn because test
results would be available only to a limited number of health
care workers and state health department employees.
The second strand of privacy protected under the Four-
teenth Amendment is autonomy. Unlike the confidentiality
analysis, the autonomy analysis is well-developed. Under
this analysis, the Supreme Court has created certain funda-
mental rights that include marriage,"' procreation,"' child-
bearing and childrearing." If a law significantly interferes
with a person's decision-making with regard to these rights, it
is subject to strict scrutiny analysis, i.e., the law must serve a
compelling governmental interest and must be narrowly tai-
lored to meet that interest.2"' Otherwise, the law need only
Servs., 433 U.S. 425, 458-59 (1977); Whalen v. Roe, 429 U.S. 589, 602 (1977).
"6 See Greenberg, 983 F.2d at 293 ("What 'personal information' and disclosure
to whom? To the government as employer or to the world?").
' But see Cumin, supra note 181, at 897-98 (Planned Parenthood v. Casey,
112 S. Ct. 2791 (1992), may have altered the autonomy analysis).
Griswold v. Connecticut, 381 U.S. 479, 485-86 (1965).
Skinner v. Oklahoma, 316 U.S. 535, 541-42 (1942).
22 Pierce v. Society of Sisters, 268 U.S. 510, 532 (1925); Meyer v. Nebraska,
262 U.S. 390, 399 (1923).
"2 See, e.g., Griswold, 381 U.S. at 495-96 (Goldberg, C.J., concurring, joined by
Brennan, J.).
In a long series of cases this Court has held that where fundamen-
tal personal liberties are involved, they may not be abridged by the
States simply on a showing that a regulatory statute has some rational
relationship to the effectuation of a proper state purpose. "Where there is
a significant encroachment upon personal liberty, the State may prevail
only upon a subordinating interest which is compelling." The law must be
shown "necessary, and not merely rationally related to, the accomplish-
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be rationally related to a legitimate governmental interest. 2
Mandatory newborn testing easily satisfies the rationality
test. The state has a legitimate interest in identifying and
treating HIV-infected newborns, and mandatory testing is a
rational way to accomplish this purpose. Although it could be
argued that identifying and treating HIV-infected newborns is
also a compelling state interest, there is no need to go beyond
the rationality test because mandatory newborn testing does
not significantly interfere with a mother's childbearing or
childrearing decisions. A woman's decision regarding whether
to bear a child or how to raise a child remains her own. Critics,
nonetheless, assert that women will decide not to bear children
because of their fear of the test or that they will abandon their
children once the results of the tests are given to them. 3
Other factors counter these arguments, however. For example,
the culture of many minority women strongly encourages them
to bear children234 and in general these women are caring
mothers." 5 Moreover, any effect that mandatory testing has
on these women must be determined in light of the high proba-
bility that, untested and untreated, an HIV-infected newborn
will become sick and reveal his or her infection within the first
year of life. In sum, mandatory newborn testing does not vio-
late the privacy interests of mothers or newborns.
ment of a permissible state policy."
Id. (citations omitted).
2Id.
See Cumin, supra note 181, at 881; see also supra note 178 and accompany-
ing text.
See Weiss, supra note 152.
Despite warnings and counseling about the risk of perinatal HIV
transmission, HIV-positive and AIDS-infected women continue to have
babies. Current studies indicate that women who are knowingly HIV-
positive become pregnant at rates similar to those of uninfected women.
Indeed, studies further disclose that HrIV- and AIDS-infected women are
becoming pregnant notwithstanding having already bore an HIV-afflicted
child or having previously lost a child to AIDS. Although HIV infection
prompts some women to seek abortions, many women do not....
The persistence of pregnancies in HIV-infected women and births of
HIV-afflicted children derive from underlying cultural, social, religious,
and personal ideologies that indisputably dictate a woman's reproductive
decisions.
Id. at 670-71 (footnotes omitted).
See supra note 178 and accompanying text.
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VI. ANALYSIS OF THE NEW YORK STATE ASSEMBLY BILL
As currently proposed, Assemblywoman Mayersohn's bill
amends the New York State Public Health Law by adding a
new subdivision under the confidentiality and disclosure sec-
tion of Article 27-F." This section allows a parent or pro-
In pertinent part, § 2782 of Article 27-F provides:
1. No person who obtains confidential HIV related information in the
course of providing any health or social service or pursuant to a release
of confidential HIV related information may disclose or be compelled to
disclose such information, except to the following:
(a) the protected individual or, when the protected individual lacks
capacity to consent, a person authorized, pursuant to law to consent
to health care for the individual;
[Other exceptions relating to health care providers, authorized foster care
or adoption agencies, insurance providers, persons authorized pursuant to
court orders, and parole, probation or correctional agents.]
2. A state, county or local health officer may disclose confidential HIV
related information when:
(a) disclosure is specifically authorized or required by federal or state
law; or
(b) disclosure is made pursuant to a release of confidential HIV re-
lated information; or
(c) disclosure is requested by a physician pursuant to subdivision
four of this section; or
(d) disclosure is authorized by court order pursuant to the provisions
of section twenty-seven hundred eighty-five of this article.
3. No person to whom confidential HIV related information has been
disclosed pursuant to this article shall disclose the information to another
person except as authorized by this article, provided, however, that the
provisions of this subdivision shall not apply:
(a) to the protected individual; or
(b) to a natural person who is authorized pursuant to law to consent
to health care for the protected individual; or
(c) to a protected individual's foster parent as defined in section
three hundred seventy-one of the social services law and subject to
regulations promulgated pursuant to paragraph (a) of subdivision two
of section twenty-seven hundred eighty-six of this article, for the
purpose of providing care, treatment or supervision of the protected
individual; or
(d) a prospective adoptive parent as specified in section three hun-
dred seventy-three-a of the social services law and subject to regula-
tions promulgated pursuant to paragraph (a) of subdivision two of
section twenty- seven hundred eighty-six of this article with whom a
child has been placed for adoption.
4. (a) A physician may disclose confidential HIV related information un-
der the following conditions:
(1) disclosure is made to a contact or to a public health officer
for the purpose of making the disclosure to said contact; and
(2) the physician reasonably believes disclosure is medically ap-
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spective adoptive parent to receive the result of a newborn's
HIV test. While this Note supports Assemblywoman's
Mayersohn's bill, it finds the bill has some shortcomings that
should be addressed before it is re-introduced to the New York
State Assembly. The following analysis critiques the bill on its
lack of clarity of purpose, its inappropriate inclusion of contact
notification, its failure to amend the New York State HIV
informed consent section, and its omission of counseling re-
quirements.
propriate and there is a significant risk of infection to the con-
tact; and
(3) the physician has counseled the protected individual regard-
ing the need to notify the contact, and the physician reasonably
believes the protected individual will not inform the contact; and
(4) the physician has informed the protected individual of his or
her intent to make such disclosure to a contact and has given
the protected individual the opportunity to express a preference
as to whether disclosure should be made by the physician di-
rectly or to a public health officer for the purpose of said disclo-
sure. If the protected individual expresses a preference for dis-
closure by a public health officer or by the physician, the physi-
cian shall honor such preference.
N.Y. PUB. HEALTH LAW § 2782 (McKinney Supp. 1993).
Under this section, the bill would add a new subdivision:
10. The department shall disclose to the mother, the prospective adoptive
parents or the appropriate official of an authorized agency having the
care, custody or guardianship of a newborn child confidential HIV related
information obtained as a result of any testing done for any purpose
whatsoever on such child, including epidemiological research, done by the
department or any person, partnership, corporation or association autho-
rized to obtain confidential HIV related information including, but not
limited to, a subsidiary agency of the department, a health care provider
or a health facility. If the mother of a newborn child cannot be located
in order to receive such information, the father or the appropriate guard-
ian of such child shall receive such notification.
New York State Assembly Bill No. 6747-C, 215th Gen. Assembly, 1st Sess. § 2
(1994). The bill also would add another subdivision under N.Y. Pub. Health Law §
1781 (McKinney Supp. 1993) to provide for testing of foster children:
7. The provisions of this section shall not apply to the performance of an
HIV related test by a health care provider or health facility upon a fos-
ter child when such test has been deemed necessary for the protection of
the health of such child or such child's foster parents or other members
of such child's foster family by the appropriate official of the authorized
agency having the care, custody or guardianship of such child.
New York State Assembly Bill No. 6747-C, 215th Gen. Assembly, 1st Sess. § 1
(1994).
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A. Need to State Clearly the Purpose of Newborn Testing
The purpose of newborn testing is to identify HIV-infected
newborns as early as possible so that these children can re-
ceive the maximum benefits from available treatments. As
obvious as this purpose may seem, it needs to be clearly enun-
ciated in the bill or legislative material because some commen-
tators have raised the concern that the real purpose of testing
is to identify HIV-infected mothers, not infants."7 Unfortu-
nately this suggestion has been bolstered by a New York State
Assembly memorandum and a newsletter from Assemblywom-
an Mayersohn's office that place undue emphasis on the pre-
vention of HIV infection through breastfeeding as a benefit of
newborn testing."8 Since only uninfected newborns benefit
from the prevention of this mode of infection, the emphasis on
this benefit bolsters the incorrect inference that the bill seeks
to identify HIV-infected mothers, regardless of the status of
the child. 9
Another factor that has tended to support the inference
that newborn testing seeks to identify infected mothers instead
of children is that infection in children currently is tested by
the presence of maternal antibodies. It should be made clear
that, at the present time, newborn testing by means of mater-
nal antibodies is the result of medical limitations and does not
indicate a hidden purpose behind the test. Ideally, as the new-
' See HIV Infection, Pregnant Women, and Newborns, supra note 42, at 2418
("Currently, and for the foreseeable future, programs of newborn screening are
defacto programs testing for HIV infection in the mother, not the infant."); Hunter,
supra note 8.
Suspicion about the motivation for mandatory testing of either pregnant
women or newborns is heightened by the context of such programs. The
government has shown no great zeal for insuring the health of babies in
the African-American and Hispanic communities, which would be the
most affected. Infant mortality rates among those communities in the
United States compare to the rates in impoverished nations, and normal
prenatal and pediatric care is often unavailable.
Id. at 17.
. New York State Assembly Memorandum in Support of Legislation, New York
Assembly Bill No. 6747 (1993) (on file with author); Newsletter from Assembly-
woman Mayersohn's Office (July 1993) (on file with author).
"' This is not to say that the prevention.of HIV infection through breastfeeding
is not important. This mode of transmission may be averted, however, by simply
informing all mothers of the risk of transmission and advising them not to
breastfeed their children unless they have tested negative for HIV.
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est tests become more widely available, only those newborns
who are themselves infected will be identified by the tests.
To eliminate misconceptions and allay fears regarding the
purpose of the bill, the New York Assembly should clarify its
legislative memorandum regarding the bill. The Assembly
should begin by clearly stating the purpose of the bill-to iden-
tify infected newborns. It should then eliminate references to
the prevention of infection through breastfeeding as a benefit
of testing. Finally, the Assembly should direct the NYSDOH to
review available testing methods each year and quickly autho-
rize newer, more selective, methods when they become avail-
able.
B. Need to Eliminate Contact Notification
Under the current Public Health Law, a doctor has the
authority to disclose confidential HIV information if the "physi-
cian reasonably believes disclosure is medically appropriate
and there is a significant risk of infection to the contact."240 A
contact is defined as a spouse, a sexual partner or a person
who has shared a hypodermic needle with the protected indi-
vidual.24 Normally, an individual may circumvent this poten-
tial disclosure by requesting an anonymous HIV test.242 This
option, however, is not available to the mother whose HIV
status is revealed as a result of mandatory newborn testing.
Therefore, she may be powerless to prevent her doctor from
disclosing her status to others. This result is unjust. It allows
greater protection to an individual who voluntarily consents to
be tested than to an individual who has not consented to be
tested. Thus, although identified women should be counseled
about the necessity to notify contacts, involuntary contact
notification should be inapplicable when women are identified
as a result of mandatory newborn testing.
240 N.Y. PuB. HEALTH LAW § 2782(4) (McKinney Supp. 1993). For the full text
of this provision, see supra note 236.
241 N.Y. PUB. HEALTH LAW § 2780(10) (McKinney Supp. 1993).
242 Id. § 2781(4).
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C. Need to Amend the Informed Consent Section
Under current law, except in certain narrow circumstan-
ces, written, informed consent is required before an HIV test
may be administered. 3 The current blinded newborn testing
falls within the ambit of § 2781(6)(b) of Article 27-F of the
Public Health Law, which provides an exception to the require-
ments of informed consent "for the purpose of research if the
testing is performed in a manner by which the identity of the
test subject is not known and may not be retrieved by the
researcher."2' Thus, it is the anonymity of the newborns that
validates the current blinded testing scheme. Once this ano-
nymity is removed, newborn testing will no longer satisfy the
informed consent requirements of the law. In order to achieve
its goal, therefore, the bill must provide an explicit exception to
informed consent. Otherwise, a mother's consent will still be
required prior to the testing of her newborn.
D. Need to Incorporate Counseling Requirements
Both pre-test and post-test counseling serve many essen-
tial functions. For example, effective pre-test counseling serves
to educate the individuals tested about HIV infection and to
reduce anxiety while they await their test result.245 In the
case of mandatory newborn testing, pre-test counseling also
serves to make the mother aware that her infant will be test-
ed. Post-test counseling is critical as well and helps individuals
who receive positive results cope with the emotional and physi-
cal stresses associated with that result. 6
Under the current Public Health Law, pre-test and post-
test counseling are required for testing performed pursuant to
written, informed consent. 7 Since these provisions do not
apply to mandatory newborn testing, the bill must explicitly
provide for counseling requirements. 8 Again, it would be un-
243 Id. § 2781(1), (6); see also supra notes 67-77 and accompanying text.
2" N.Y. PUB. HEALTH LAW § 2781(6)(b) (McKinney Supp. 1993).
21 See Closen, supra note 162, at 471. See generally STINE, supra note 5, at
321-23.
2' See Closen, supra note 162, at 471. See generally STINE, supra note 5, at
321-23.
247 N.Y. PUB. HEALTH LAW § 2781(3), (5) (McKinney Supp. 1993).
245 A Senate bill was introduced this past session that would mandate counsel-
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fair to provide persons who voluntarily consented to be tested
with more support than persons who did not consent to be
tested. Furthermore, in the context of newborn testing, coun-
seling is especially important because the result affects a
whole family, not just one person."
CONCLUSION
Given the significant advantages of early treatments avail-
able for HIV-infected newborns, it is imperative that New York
State adopt a newborn testing program. Moreover, the program
must be mandatory: data collected from voluntary testing pro-
grams over the last several years shows that such programs
have failed to identify over one-half of the infected children
that were born in the state. Notwithstanding these statistics,
however, opponents of mandatory testing cling to the success of
the Harlem Hospital program as a model for future voluntary
programs. Other arguments aside, it must be realized that the
Harlem Hospital program is a true anomaly-it has been the
only successful voluntary program in the entire state. There-
fore, there is no reason to believe that it can be replicated on a
larger scale. In addition, arguments by opponents of mandato-
ry testing relating to the costs and problems of such testing are
flawed. The costs of HIV infection and the problems with the
health care system must be addressed responsibly by any test-
ing program, whether mandatory or voluntary. Finally, argu-
ments relating to the privacy interests of the mothers of new-
borns are also flawed. The privacy interests of mothers are
largely protected by the strict confidentiality laws in New York
State. Moreover, because an HIV-infected newborn faces a high
risk of developing deadly opportunistic infections early in life,
such privacy most likely would be short-lived even if a new-
born were not tested. One mother, who discovered too late that
her child was HIV-infected, has aptly summed up the current
state of affairs by describing the current, blinded testing pro-
ing of pregnant women. New York State Senate Bill No. 6775, 215th Gen. Assem-
bly, 2d Sess. (1994). While this bill was intended to be an alternative to Assem-
blywoman Mayersohn's bill, this Note argues that both bills are necessary compo-
nents of a newborn testing scheme.
249 Moreover, pre-test counseling would have the desirable, collateral effect of
educating non-infected people and people in low-risk groups about HIV.
[Vol. 60: 407
1994] PROPOSAL TO UNBLIND HiV TESTING FOR NEWBORNS 459
gram as "sacrificing infants on the altar of privacy."'
Leonardo Renna"m
" Nat Hentoff, Sacrificing Infants on the Altar of Privacy, VILLAGE VOICE, May
10, 1994, at 16.
251 The author gratefully acknowledges the assistance of Professor Colin
Crawford of Brooklyn Law School for constructive criticisms on drafts of this Note.

